<?properties open_access?>
<?subarticle pcbi.1007665.r001?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS Comput. Biol</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-id journal-id-type="pmc">ploscomp</journal-id>
    <journal-title-group>
      <journal-title>PLoS Computational Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1553-734X</issn>
    <issn pub-type="epub">1553-7358</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7108742</article-id>
    <article-id pub-id-type="pmid">32176694</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1007665</article-id>
    <article-id pub-id-type="publisher-id">PCOMPBIOL-D-19-01225</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Biomarkers</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Hormones</subject>
            <subj-group>
              <subject>Estrogens</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Research Design</subject>
          <subj-group>
            <subject>Clinical Research Design</subject>
            <subj-group>
              <subject>Survival Analysis</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Mathematical and Statistical Techniques</subject>
          <subj-group>
            <subject>Statistical Methods</subject>
            <subj-group>
              <subject>Survival Analysis</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Mathematics</subject>
          <subj-group>
            <subject>Statistics</subject>
            <subj-group>
              <subject>Statistical Methods</subject>
              <subj-group>
                <subject>Survival Analysis</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Nucleic acids</subject>
            <subj-group>
              <subject>RNA</subject>
              <subj-group>
                <subject>Non-coding RNA</subject>
                <subj-group>
                  <subject>Natural antisense transcripts</subject>
                  <subj-group>
                    <subject>MicroRNAs</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Gene expression</subject>
            <subj-group>
              <subject>Gene regulation</subject>
              <subj-group>
                <subject>MicroRNAs</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Body Fluids</subject>
            <subj-group>
              <subject>Interstitial Fluid</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Body Fluids</subject>
            <subj-group>
              <subject>Interstitial Fluid</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Physiology</subject>
          <subj-group>
            <subject>Body Fluids</subject>
            <subj-group>
              <subject>Interstitial Fluid</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Physiology</subject>
          <subj-group>
            <subject>Body Fluids</subject>
            <subj-group>
              <subject>Interstitial Fluid</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Bioinformatics</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Computer and Information Sciences</subject>
        <subj-group>
          <subject>Data Management</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Computational Techniques</subject>
          <subj-group>
            <subject>Computational Pipelines</subject>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CAncer bioMarker Prediction Pipeline (CAMPP)—A standardized framework for the analysis of quantitative biological data</article-title>
      <alt-title alt-title-type="running-head">CAMPP - A standardized framework for the analysis of biological data</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Terkelsen</surname>
          <given-names>Thilde</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Conceptualization</role>
        <role content-type="http://credit.casrai.org/">Data curation</role>
        <role content-type="http://credit.casrai.org/">Formal analysis</role>
        <role content-type="http://credit.casrai.org/">Investigation</role>
        <role content-type="http://credit.casrai.org/">Methodology</role>
        <role content-type="http://credit.casrai.org/">Software</role>
        <role content-type="http://credit.casrai.org/">Validation</role>
        <role content-type="http://credit.casrai.org/">Visualization</role>
        <role content-type="http://credit.casrai.org/">Writing – original draft</role>
        <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Krogh</surname>
          <given-names>Anders</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Methodology</role>
        <role content-type="http://credit.casrai.org/">Supervision</role>
        <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff002">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7376-5894</contrib-id>
        <name>
          <surname>Papaleo</surname>
          <given-names>Elena</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Conceptualization</role>
        <role content-type="http://credit.casrai.org/">Funding acquisition</role>
        <role content-type="http://credit.casrai.org/">Investigation</role>
        <role content-type="http://credit.casrai.org/">Methodology</role>
        <role content-type="http://credit.casrai.org/">Project administration</role>
        <role content-type="http://credit.casrai.org/">Resources</role>
        <role content-type="http://credit.casrai.org/">Supervision</role>
        <role content-type="http://credit.casrai.org/">Writing – original draft</role>
        <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="aff003">
          <sup>3</sup>
        </xref>
        <xref ref-type="corresp" rid="cor001">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Computational Biology Laboratory, Danish Cancer Society Research Center and Center for Autophagy, Recycling and Disease, Copenhagen, Denmark</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Unit of Computational and RNA biology, Department of Biology, University of Copenhagen, Copenhagen Denmark</addr-line>
    </aff>
    <aff id="aff003">
      <label>3</label>
      <addr-line>Translational Disease System Biology, Faculty of Health and Medical Science, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Editor</role>
        <xref ref-type="aff" rid="edit1"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>Johns Hopkins University, UNITED STATES</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p>The authors have declared that no competing interests exist.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>elenap@cancer.dk</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>16</day>
      <month>3</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <month>3</month>
      <year>2020</year>
    </pub-date>
    <volume>16</volume>
    <issue>3</issue>
    <elocation-id>e1007665</elocation-id>
    <history>
      <date date-type="received">
        <day>23</day>
        <month>7</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>18</day>
        <month>1</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2020 Terkelsen et al</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>Terkelsen et al</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pcbi.1007665.pdf"/>
    <abstract>
      <p>With the improvement of -omics and next-generation sequencing (NGS) methodologies, along with the lowered cost of generating these types of data, the analysis of high-throughput biological data has become standard both for forming and testing biomedical hypotheses. Our knowledge of how to normalize datasets to remove latent undesirable variances has grown extensively, making for standardized data that are easily compared between studies. Here we present the CAncer bioMarker Prediction Pipeline (CAMPP), an open-source R-based wrapper (<ext-link ext-link-type="uri" xlink:href="https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP">https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline -CAMPP</ext-link>) intended to aid bioinformatic software-users with data analyses. CAMPP is called from a terminal command line and is supported by a user-friendly manual. The pipeline may be run on a local computer and requires little or no knowledge of programming. To avoid issues relating to R-package updates, a renv .lock file is provided to ensure R-package stability. Data-management includes missing value imputation, data normalization, and distributional checks. CAMPP performs (I) k-means clustering, (II) differential expression/abundance analysis, (III) elastic-net regression, (IV) correlation and co-expression network analyses, (V) survival analysis, and (VI) protein-protein/miRNA-gene interaction networks. The pipeline returns tabular files and graphical representations of the results. We hope that CAMPP will assist in streamlining bioinformatic analysis of quantitative biological data, whilst ensuring an appropriate bio-statistical framework.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100012774</institution-id>
            <institution>Innovationsfonden</institution>
          </institution-wrap>
        </funding-source>
        <award-id>5189-00052B</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7376-5894</contrib-id>
          <name>
            <surname>Papaleo</surname>
            <given-names>Elena</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001732</institution-id>
            <institution>Danmarks Grundforskningsfond</institution>
          </institution-wrap>
        </funding-source>
        <award-id>DNRF125</award-id>
      </award-group>
      <award-group id="award003">
        <funding-source>
          <institution>LEO Fondet (DK)</institution>
        </funding-source>
        <award-id>LF17006</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7376-5894</contrib-id>
          <name>
            <surname>Papaleo</surname>
            <given-names>Elena</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award004">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002808</institution-id>
            <institution>Carlsbergfondet</institution>
          </institution-wrap>
        </funding-source>
        <award-id>CF18-0314</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7376-5894</contrib-id>
          <name>
            <surname>Papaleo</surname>
            <given-names>Elena</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>EP received funds from Innovationsfonden (grant number 5189-00052B), Danmarks Grundforskningsfond (grant number DNRF125), and LEO foundation exploratory grant (grant number LF17006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="8"/>
      <table-count count="2"/>
      <page-count count="20"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>PLOS Publication Stage</meta-name>
        <meta-value>vor-update-to-uncorrected-proof</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>Publication Update</meta-name>
        <meta-value>2020-03-31</meta-value>
      </custom-meta>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>All data are available without restriction in GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP">https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP</ext-link>.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>All data are available without restriction in GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP">https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP</ext-link>.</p>
  </notes>
</front>
<body>
  <sec sec-type="intro" id="sec001">
    <title>Introduction</title>
    <p>The availability of sensitive and specific biomarkers for disease diagnosis, prognosis, and monitoring, is an attractive alternative to many of the current methods in use. The presence and levels of certain tissue-derived molecular markers can help distinguish subtypes in heterogeneous diseases such as cancer [<xref rid="pcbi.1007665.ref001" ref-type="bibr">1</xref>,<xref rid="pcbi.1007665.ref002" ref-type="bibr">2</xref>]. Biomarkers may also be predictive of patient outcome and responsiveness to treatment [<xref rid="pcbi.1007665.ref003" ref-type="bibr">3</xref>,<xref rid="pcbi.1007665.ref004" ref-type="bibr">4</xref>]. Alas, pinpointing robust cancer biomarkers may be a challenging endeavor. In a review from 2014, Yotsukura and Mamitsuka [<xref rid="pcbi.1007665.ref005" ref-type="bibr">5</xref>] showed that out of 7720 publications on biomarkers usage, only 407 of these were patented, and none had obtained FDA approval [<xref rid="pcbi.1007665.ref005" ref-type="bibr">5</xref>]. One of the main limitations of biomarker research often relates to small sample size, yielding over-fitted and unreproducible results [<xref rid="pcbi.1007665.ref006" ref-type="bibr">6</xref>,<xref rid="pcbi.1007665.ref007" ref-type="bibr">7</xref>]. Other pitfalls include a lack of standardized data curation [<xref rid="pcbi.1007665.ref008" ref-type="bibr">8</xref>], inappropriate statistical analysis, and lack of validation [<xref rid="pcbi.1007665.ref006" ref-type="bibr">6</xref>,<xref rid="pcbi.1007665.ref009" ref-type="bibr">9</xref>,<xref rid="pcbi.1007665.ref010" ref-type="bibr">10</xref>]. Evaluation of marker specificity and sensitivity is pivotal as most cancer biomarkers have high false-positive rates since a range of non-cancerous events may cause changes in levels of specific biomolecules. Despite these limitations, macromolecular markers remain a promising strategy for diagnosis and subtyping of cancer, as well as other diseases. With the advancements in the field of high throughput data and the increased attention to data normalization and statistical modeling, some drawbacks of biomarker mining may be overcome in the foreseeable future [<xref rid="pcbi.1007665.ref011" ref-type="bibr">11</xref>].</p>
    <p>Central to the identification of novel disease markers is the bioinformatic analysis of high throughput biological data [<xref rid="pcbi.1007665.ref012" ref-type="bibr">12</xref>–<xref rid="pcbi.1007665.ref016" ref-type="bibr">16</xref>]. By applying different statistical tests and machine learning approaches, researchers can go from large datasets with quantitative measurements to a few biomolecules of interest [<xref rid="pcbi.1007665.ref017" ref-type="bibr">17</xref>–<xref rid="pcbi.1007665.ref021" ref-type="bibr">21</xref>]. Ideally, biomarker studies of the same disease should be reasonably comparable; however, discrepancies of results are not at all uncommon. While some of these differences arise from variances in study design and experimental procedures, a significant proportion is due to alternating and sometimes inappropriate data normalization and bioinformatic analysis pipeline [<xref rid="pcbi.1007665.ref022" ref-type="bibr">22</xref>–<xref rid="pcbi.1007665.ref024" ref-type="bibr">24</xref>]. Standardizing the framework for the detection of biomarker candidates both in the wet lab [<xref rid="pcbi.1007665.ref025" ref-type="bibr">25</xref>], as well as the dry lab, should enable researchers to more directly compare results across different studies and starting materials [<xref rid="pcbi.1007665.ref024" ref-type="bibr">24</xref>,<xref rid="pcbi.1007665.ref026" ref-type="bibr">26</xref>].</p>
    <p>We here illustrate The CAncer bioMarker Prediction Pipeline (CAMPP), which is an R-based command-line wrapper for the analysis of high throughput data. The intention behind CAMPP is to provide bioinformatic software-users with a standardized way of screening for potential disease markers, and other biomolecules of interest, prior to potential experimental validation. We have aimed for a pipeline that is intuitive and well-documented, as is good practice [<xref rid="pcbi.1007665.ref027" ref-type="bibr">27</xref>].</p>
  </sec>
  <sec sec-type="materials|methods" id="sec002">
    <title>Design and implementation</title>
    <sec id="sec003">
      <title>Requirements</title>
      <p>The main prerequisite for CAMPP is R and Rstudio. Furthermore, Macbook users must have Xcode installed [<ext-link ext-link-type="uri" xlink:href="https://developer.apple.com/xcode/">https://developer.apple.com/xcode/</ext-link>], while windows users must ensure they have some equivalent of command-line tools.</p>
      <p>Currently, CAMPP is a command-line tool run using Rscript, which is automatically acquired when installing R and Rstudio (most likely path; <italic>/usr/local/bin/Rscript)</italic>. Minimum requirements; <italic>R version 3</italic>.<italic>5</italic>.<italic>1</italic> and <italic>Rstudio version 1</italic>.<italic>1</italic>.<italic>463</italic>.</p>
    </sec>
    <sec id="sec004">
      <title>Set-up and package stability</title>
      <p>The first time the pipeline is run, all R-packages and dependencies are automatically checked and installed. For installation, a default CRAN mirror is employed; however, this may easily be changed to better fit user location (<ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/mirrors.html">https://cran.r-project.org/mirrors.html</ext-link>).</p>
      <p><italic>Renv</italic>: As updates of R-packages are regular, there is a chance that the code will break, and we therefore also provide the user with the option to use an R-package “freeze”, in the form of a <italic>renv</italic> [<xref rid="pcbi.1007665.ref028" ref-type="bibr">28</xref>]. To use the <italic>renv</italic> packages, the user must run CAMPP with the argument flag, <italic>-e</italic>, set to “stable”.</p>
      <p>The CAMPPFunctions.R contains custom functions sourced by the CAMPP.R script (main script), and, as such, these two scripts must be located in the same working directory.</p>
      <p>CAMPP may be used to perform a variety of analyses, including preliminary data management, summarized in <xref rid="pcbi.1007665.t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="pcbi.1007665.g001">Fig 1A</xref> below. As the analyses with CAMPP are standardized, the pipeline accepts a range of biological datasets from different high throughput sequencing platforms.</p>
      <fig id="pcbi.1007665.g001" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <p><bold>A.</bold> Diagram depicting the different types of methodologies and analyses employed by the CAncer bioMarker Prediction Pipeline (CAMPP). <bold>B.</bold> Diagram depicting the structure of CAMPP output, with folders and subfolders organized by analyses.</p>
        </caption>
        <graphic xlink:href="pcbi.1007665.g001"/>
      </fig>
      <table-wrap id="pcbi.1007665.t001" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Table summarizing preliminary data management and analyses implemented in CAMPP, along with specific methods and underlying R-packages.</title>
        </caption>
        <alternatives>
          <graphic id="pcbi.1007665.t001g" xlink:href="pcbi.1007665.t001"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1">Type</th>
                <th align="left" rowspan="1" colspan="1">R-package</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">
                  <bold>Preliminary Data Management</bold>
                </td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Missing Value Imputation</td>
                <td align="left" rowspan="1" colspan="1">K-nearest neighbor</td>
                <td align="left" rowspan="1" colspan="1">impute [<xref rid="pcbi.1007665.ref030" ref-type="bibr">30</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Data Normalization</td>
                <td align="left" rowspan="1" colspan="1">Normalize between arrays and mean/median centering</td>
                <td align="left" rowspan="1" colspan="1">R Base</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Data Transformation</td>
                <td align="left" rowspan="1" colspan="1">log2, log10, logit, voom</td>
                <td align="left" rowspan="1" colspan="1">R Base</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Data Distribution Fitting</td>
                <td align="left" rowspan="1" colspan="1">Normal, Weibull, Lognormal, Gamma, Poisson, Binomial</td>
                <td align="left" rowspan="1" colspan="1">fitdistrplus [<xref rid="pcbi.1007665.ref035" ref-type="bibr">35</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
                  <bold>Analysis</bold>
                </td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">K-means Clustering</td>
                <td align="left" rowspan="1" colspan="1">Hartigan and Wong algorithm, BIC</td>
                <td align="left" rowspan="1" colspan="1">R Base, mclust [<xref rid="pcbi.1007665.ref036" ref-type="bibr">36</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Differential Expression/Abundance Analysis</td>
                <td align="left" rowspan="1" colspan="1">Empirical Bayes Framework for Linear Models</td>
                <td align="left" rowspan="1" colspan="1">edgeR [<xref rid="pcbi.1007665.ref032" ref-type="bibr">32</xref>], limma [<xref rid="pcbi.1007665.ref037" ref-type="bibr">37</xref>], sva [<xref rid="pcbi.1007665.ref041" ref-type="bibr">41</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">LASSO / Elastic-Net Regression</td>
                <td align="left" rowspan="1" colspan="1">Group LASSO/EN—multinomial</td>
                <td align="left" rowspan="1" colspan="1">glmnet [<xref rid="pcbi.1007665.ref042" ref-type="bibr">42</xref>], pROC [<xref rid="pcbi.1007665.ref043" ref-type="bibr">43</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Co-Expression/Abundance Correlations</td>
                <td align="left" rowspan="1" colspan="1">WGCNA, Pearson, Spearman</td>
                <td align="left" rowspan="1" colspan="1">WGCNA [<xref rid="pcbi.1007665.ref044" ref-type="bibr">44</xref>], R Base</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Survival Analysis</td>
                <td align="left" rowspan="1" colspan="1">Cox Proportional Hazard Regression</td>
                <td align="left" rowspan="1" colspan="1">survcomp [<xref rid="pcbi.1007665.ref045" ref-type="bibr">45</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Interaction Networks</td>
                <td align="left" rowspan="1" colspan="1">STRING [<xref rid="pcbi.1007665.ref047" ref-type="bibr">47</xref>], miRTarBase [<xref rid="pcbi.1007665.ref048" ref-type="bibr">48</xref>] and TargetScan [<xref rid="pcbi.1007665.ref049" ref-type="bibr">49</xref>]</td>
                <td align="left" rowspan="1" colspan="1">multiMiR [<xref rid="pcbi.1007665.ref050" ref-type="bibr">50</xref>]</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec id="sec005">
      <title>User input</title>
      <p>The user must provide; (I) a matrix with expression/abundance values, (II) a metadata file which should contain at least two columns, a column with sample ids, matching the column names in the expression/abundance file and a column specifying which group (disease state, treatment etc.) a given sample belongs to and (III) the user has to specify which type (variant) of data is provided for analysis, current options are; a<italic>rray</italic>, <italic>seq</italic>, <italic>ms or other</italic>.</p>
    </sec>
    <sec id="sec006">
      <title>Value imputation and pseudocounts</title>
      <p>If the input data contains missing expression values, these will automatically be imputed using Local Least Squares Imputation, LLSI [<xref rid="pcbi.1007665.ref029" ref-type="bibr">29</xref>], or K-Nearest Neighbor Imputation, KNNI [<xref rid="pcbi.1007665.ref030" ref-type="bibr">30</xref>]. The default method is LLSI, as this type of imputation has been shown to perform better on expression data [<xref rid="pcbi.1007665.ref031" ref-type="bibr">31</xref>].</p>
    </sec>
    <sec id="sec007">
      <title>Data normalization, filtering, and transformation</title>
      <p>For RNA sequencing data (<italic>seq</italic>) variables with low counts over all groups (tissue, treatment) are filtered out, library sizes are scaled (weighted trimmed mean of M-values, TMM) [<xref rid="pcbi.1007665.ref032" ref-type="bibr">32</xref>], and data are voom-transformed [<xref rid="pcbi.1007665.ref017" ref-type="bibr">17</xref>]. For microarray data, (<italic>array</italic>) data are log2-transformed and either quantile normalized [<xref rid="pcbi.1007665.ref032" ref-type="bibr">32</xref>,<xref rid="pcbi.1007665.ref033" ref-type="bibr">33</xref>] or standardized using mean or median [<xref rid="pcbi.1007665.ref034" ref-type="bibr">34</xref>]. Mass spectrometry data (<italic>ms</italic>), are log-transformed (log2, log10, or logit) and standardized using mean or median [<xref rid="pcbi.1007665.ref034" ref-type="bibr">34</xref>].</p>
    </sec>
    <sec id="sec008">
      <title>Preliminary data distributional checks</title>
      <p>As default, the pipeline utilized the R-package <italic>fitdistrplus</italic> [<xref rid="pcbi.1007665.ref035" ref-type="bibr">35</xref>] to generate skewness-kurtosis plots (Cullen and Frey graphs) for ten randomly selected variables. Distributions are fitted to data by maximum likelihood, and parameters of the distribution are estimated with bootstrap-resampling to simulate variability [<xref rid="pcbi.1007665.ref035" ref-type="bibr">35</xref>]. In addition to the Cullen and Frey graphs, histograms, quantile-quantile, and probability-probability plots are returned.</p>
    </sec>
    <sec id="sec009">
      <title>Clustering of samples</title>
      <p>CAMPP will test several of centroids for K-means clustering, the exact number of which will depend on the size of the dataset. After clustering, the R-package <italic>mclust</italic> [<xref rid="pcbi.1007665.ref036" ref-type="bibr">36</xref>] is employed to evaluate which number of clusters is “optimal” for the input data, based on the Bayesian Information Criterion (BIC). The pipeline will return an Multidimensional Scaling (MDS) plot depicting the “best” clustering of samples. In addition, CAMPP will output the original metadata file with a column specifying which cluster each sample was assigned to. If desired, the user may re-run CAMPP, using the k-means column for variable selection.</p>
    </sec>
    <sec id="sec010">
      <title>Variable selection with differential expression analysis and elastic-net regression</title>
      <p>Variable selection with CAMPP employs <italic>limma</italic> (linear models for microarray data) for differential expression/abundance analysis (DEA, DAA) [<xref rid="pcbi.1007665.ref037" ref-type="bibr">37</xref>]. <italic>Limma</italic> was originally designed for analysis of microarray data and subsequently revised to handle RNA sequencing data. However, this software is very flexible and has recently been shown to also perform very well with quantitative mass spectrometry data [<xref rid="pcbi.1007665.ref038" ref-type="bibr">38</xref>,<xref rid="pcbi.1007665.ref039" ref-type="bibr">39</xref>]. In addition to being versatile, <italic>limma</italic> has been shown to work exceptionally well on datasets with small sample sizes [<xref rid="pcbi.1007665.ref017" ref-type="bibr">17</xref>,<xref rid="pcbi.1007665.ref040" ref-type="bibr">40</xref>]. DEA may be performed with correlation for experimental batches and other confounders. Batch-correction is performed by directly incorporating batches into the model design matrix [<xref rid="pcbi.1007665.ref041" ref-type="bibr">41</xref>]. Batch correction is achieved by specifying the name of the column in the metadata file, which contains the batch information (with flag <italic>-b</italic>)—see user manual for specifics.</p>
      <p>As DEA most often yields a long list of variables, CAMPP also performs Least Absolute Shrinkage and Selection Operator (LASSO) or Elastic Net (EN) regression with <italic>glmnet</italic> [<xref rid="pcbi.1007665.ref042" ref-type="bibr">42</xref>].</p>
      <p>EN/LASSO may be performed in two ways; (I) the dataset is split into training and testing subsets, k-fold cross-validation is performed on the training dataset, followed by estimation of specificity and sensitivity (area under the curve = AUC) [<xref rid="pcbi.1007665.ref043" ref-type="bibr">43</xref>] using the test dataset, or (Il) k-fold cross validation is performed using the full dataset. CAMPP will automatically estimate whether the input dataset is large enough to split. The pipeline will perform regression analysis ten times and output bar-plots of cross-validation errors and AUCs for each run. Results of DEA, LASSO/EN regression, and the overlap between these are output in tables.</p>
    </sec>
    <sec id="sec011">
      <title>Weighted co-expression network analysis</title>
      <p>CAMPP may be used to perform Spearman correlation analysis, with testing for significance and correction for multiple testing (FDR). The user may perform a Weighted Gene Co-Expression Network Analysis. For this type of analysis, CAMPP relies on the R-package WGCNA [<xref rid="pcbi.1007665.ref044" ref-type="bibr">44</xref>]. To reduce the contribution from low correlations, mainly assumed to be noise, the WGCNA software estimates soft thresholding powers for exponentiation. Co-expression analysis will result in a plot of variable clustering, before merging and after merging of modules (modules with &lt; 25% dissimilarity are merged by default). A heatmap showing the strength of variable co-expression within each module will be generated, if the module contains &lt; = 100 variables—more than this will yield an unreadable plot. CAMPP will return tabular .txt files, one from each module, with the topmost interconnected variables within a module (default is 25%) and accompanying interconnectivity score plots.</p>
    </sec>
    <sec id="sec012">
      <title>Survival analysis—Pinpointing prognostic biomarkers</title>
      <p>Users may perform survival analysis with Cox proportional hazard regression [<xref rid="pcbi.1007665.ref045" ref-type="bibr">45</xref>] within CAMPP. To run survival analysis, the provided metadata file must contain at least three columns; <italic>age</italic> = age in years at diagnosis, surgery, or entry into trial, <italic>outcome</italic>.<italic>time =</italic> time until the end of follow-up and <italic>outcome</italic> = specifying censuring or death (0 or 1). In addition to age, the user wishes to correct for other potential confounders. The pipeline checks two underlying assumptions of the Cox model before performing survival analysis: (I) a linear relationship of continuous covariates with log hazards, and (II) proportional hazards of categorical and continuous covariates, i.e., constant relative hazard [<xref rid="pcbi.1007665.ref046" ref-type="bibr">46</xref>]. If the requirement of linearity is not fulfilled, cubic splines will be added to the covariate(s) in question.</p>
    </sec>
    <sec id="sec013">
      <title>Interaction networks</title>
      <p>After variable selection, the user may generate protein-protein and/or miRNA-gene interaction networks. If gene expression data are used as input for CAMPP, protein-protein interactions are retrieved from the STRING database [<xref rid="pcbi.1007665.ref047" ref-type="bibr">47</xref>], and pairs, where both genes (proteins) are differentially expressed, are extracted. The pipeline can accept a variety of gene identifiers. If miRNA expression data are used as input, then miRNA-gene interaction pairs are retrieved from either miRTarBase (validated targets) [<xref rid="pcbi.1007665.ref048" ref-type="bibr">48</xref>], TargetScan (predicted) [<xref rid="pcbi.1007665.ref049" ref-type="bibr">49</xref>], or a combination of both [<xref rid="pcbi.1007665.ref050" ref-type="bibr">50</xref>]. Mature miRNA identifiers or miRNA accession are allowed as input. If the user has both gene and miRNA expression values from the same sample cohort, both protein-protein and miRNA-gene pairs are retrieved, and the results are combined. In this case, the pipeline will return pairs where the fold changes of gene and miRNA are inverse, one up-regulated and the other down-regulated. Interaction network analysis with CAMPP will result in a tabular .txt file with all extracted interactions, including logFCs, FDRs, and interaction scores. This file may be used for visualization of networks with Cytoscape [<xref rid="pcbi.1007665.ref051" ref-type="bibr">51</xref>] or another similar tool. In addition, a plot of the top 100 “strongest” interactions are returned.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="sec014">
    <title>Results</title>
    <sec id="sec015">
      <title>Case Study 1</title>
      <p>Analysis of Single-Channel Microarray Data, Variable Selection, WGCNA and, Gene-Gene Interactions.</p>
      <p>For the testing of an array dataset, we used mRNA expression data from single-channel microarrays [<xref rid="pcbi.1007665.ref052" ref-type="bibr">52</xref>]. The dataset contained 80 breast tumor samples with expression quantified for ~ 15.000 mRNAs. Clinical data included, among other things, information on the classification in breast cancer subtypes. Data were background-corrected for ambient intensities before analysis.</p>
      <p>We used CAMPP to perform variable selection. Missing values were imputed, data were log2 transformed and normalized between arrays. Additionally, data were corrected for experimental batches and tumor immune scores. Variables with the ability to separate patient estrogen receptor status (ER+ vs. ER-) were selected with elastic-net (alpha = 0.5) and DEA. For this contrast, patient distribution across the two groups was balanced, and CAMPP divided the data into training and testing sets. Subtype-specific expression profiles were also compared; however, as only nine samples where available for one of the subtypes, elastic-net regression was performed without splitting the dataset. As the lack of a test set increases the chance of overfitting significantly, elastic-net results merely provided support for DEA results.</p>
      <p><xref ref-type="fig" rid="pcbi.1007665.g002">Fig 2</xref> shows an example of the data checks performed with <italic>fitdistrplus</italic> [<xref rid="pcbi.1007665.ref035" ref-type="bibr">35</xref>] on a set of n (default is 10) randomly extracted variables from the dataset. The gene used as an example in <xref ref-type="fig" rid="pcbi.1007665.g002">Fig 2</xref> is FAM27E2 (Family With Sequence Similarity 27 Member E2), randomly selected from the ten data check plots. FAM27E2 and the other nine genes tested by random, all displayed approximate normal distributions, indicating that these were appropriate for further analysis (see specifics on this in user manual in the GitHub repository). <xref ref-type="fig" rid="pcbi.1007665.g003">Fig 3</xref> shows the number of up- and down-regulated genes from DEA overlapped with results of elastic-net regression, for the comparison of estrogen receptor status (ER- vs. ER+). <xref ref-type="fig" rid="pcbi.1007665.g003">Fig 3</xref> also contains a MDS plot for data-overview and statistics on cross-validation error and area under the curve (AUCs) for each of the ten elastic-net runs. Lists of DE genes, results of LASSO regression, and all plots may be found in the <italic>GitHub repository (CS1</italic>.<italic>zip)</italic>.</p>
      <fig id="pcbi.1007665.g002" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>The output of a CAMPP data check.</title>
          <p>The gene used in this example is FAM27E2, randomly selected from the ten variable check plots. Top panel from the left; Cullen and Frey graph showing skewness and kurtosis of normalized and transformed expression data and histogram with different distribution models overlayed. Lower panel from left, quantile-quantile, and probability-probability plot.</p>
        </caption>
        <graphic xlink:href="pcbi.1007665.g002"/>
      </fig>
      <fig id="pcbi.1007665.g003" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <title>Results of gene selection using DEA and elastic-net regression.</title>
          <p>The dataset contained ~ 15.000 genes and 80 samples, groups used for contrast were estrogen positive (n = 61) vs estrogen negative samples (n = 19). Fig 3A is a multidimensional scaling plot showing the partitioning of samples (based on all genes), colored by estrogen status. Fig 3B shows the overlap of results from elastic-net regression (alpha = 0.5) and differential expression analysis with significance cutoffs logFC &gt; 1 or &lt; -1 and FDR &lt; 0.05. Fig 3C depicts the performance statistics for elastic-net regression, e.g., 10-fold cross-validation errors and area under the curve (AUC) scores for the test set. Elastic-net is run 10 times with different random seeds.</p>
        </caption>
        <graphic xlink:href="pcbi.1007665.g003"/>
      </fig>
      <p>As seen from <xref ref-type="fig" rid="pcbi.1007665.g003">Fig 3B</xref>, a total of 147 genes were found to be down-regulated in ER- vs ER+ (up in ER+), while 156 genes were up-regulated in ER- vs. ER+ (down in ER+). Elastic-Net regression resulted in 20 genes, out of which nine overlapped with DEA results. Plots of cross-validation errors and AUCs displayed good convergence, with AUCs ranging between 0.96–1.0. The inspection of the nine genes from the overlap between DEA and elastic-net revealed that two of these were Estrogen Receptor 1 and RAS Like Estrogen Regulated Growth Inhibitor, both up-regulated in the ER+ samples compared to ER- samples, in accordance with expectation [<xref rid="pcbi.1007665.ref053" ref-type="bibr">53</xref>]. Two of the genes which were up-regulated in ER-negative samples encoded for solute carriers, known to be associated with more aggressive types of breast cancer [<xref rid="pcbi.1007665.ref054" ref-type="bibr">54</xref>–<xref rid="pcbi.1007665.ref056" ref-type="bibr">56</xref>]. The heatmap in <xref ref-type="fig" rid="pcbi.1007665.g004">Fig 4</xref> shows the partitioning of breast tissue samples based on the consensus set of variables from DE analysis and elastic-net regression.</p>
      <fig id="pcbi.1007665.g004" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.g004</object-id>
        <label>Fig 4</label>
        <caption>
          <title>The heatmap in Fig 4 shows the partitioning breast cancer tissues into estrogen receptor-positive (ER+) samples and estrogen receptor-negative (ER-) samples, based on the consensus set of variables from differential expression analysis and elastic-net regression.</title>
          <p>Green = ER+ samples and Purple = ER- samples. Color scale of heatmap (blue to yellow) denotes log2 fold change.</p>
        </caption>
        <graphic xlink:href="pcbi.1007665.g004"/>
      </fig>
      <p>In summary, a total of 290 genes were differentially expressed between subtypes, out of which 20 were also identified by elastic-net regression—in total elastic-net returned 42 genes. The set of 20 consensus genes encompassed many well-known genes with the potential to distinguish subtypes. In addition to three Pam50 genes; ERBB2, ESR1 and FOXA1 [<xref rid="pcbi.1007665.ref057" ref-type="bibr">57</xref>], the consensus set included; C1orf64 (ER-related factor, ERRF) which was down-regulated in TNBC, in accordance with literature [<xref rid="pcbi.1007665.ref058" ref-type="bibr">58</xref>,<xref rid="pcbi.1007665.ref059" ref-type="bibr">59</xref>], CDK12, which was up-regulated in Her2 samples, supported by literature indicating that a total of 71% of Her2-enriched tumors overexpress this gene [<xref rid="pcbi.1007665.ref060" ref-type="bibr">60</xref>]. Other genes of interest were CYP2B6 [<xref rid="pcbi.1007665.ref061" ref-type="bibr">61</xref>], MYLK3 [<xref rid="pcbi.1007665.ref062" ref-type="bibr">62</xref>], and SLURP1 [<xref rid="pcbi.1007665.ref063" ref-type="bibr">63</xref>].</p>
      <p>We used CAMPP to perform WGCNA. In this example, WGCNA was generated only for the DE genes. <xref ref-type="fig" rid="pcbi.1007665.g005">Fig 5</xref> shows a subset of results from WGCNA with genes DE between breast cancer subtypes. <xref ref-type="fig" rid="pcbi.1007665.g005">Fig 5</xref> sub-Figs; (I) 5A, a module dendrogram, (II) 5B, an example of a module heatmap showing co-expression of genes in one of the small modules, module 2, and (III) 5C, an example of a module interconnectivity plot, for the top 25% (default setting) most interconnected genes in module 2. The six genes returned as the most interconnected in this module were strongly associated with the Her2-enriched BC subtype. These genes included ERBB2 (HER2 itself), GRB7 (a Pam50 classifier gene) and MIEN1, CDK12, PGAP3, and TCAP, all of which are ERBB2 amplicon passenger genes [<xref rid="pcbi.1007665.ref064" ref-type="bibr">64</xref>–<xref rid="pcbi.1007665.ref066" ref-type="bibr">66</xref>].</p>
      <fig id="pcbi.1007665.g005" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.g005</object-id>
        <label>Fig 5</label>
        <caption>
          <title>Results of Weighted Gene Co-expression Network Analysis on dataset of ~ 15.000 genes and 80 samples.</title>
          <p>As the dataset contained more than 5000 variables, WGCNA was performed in a block-wise manner to save computational time, in accordance with the WGCNA reference manual [<xref rid="pcbi.1007665.ref044" ref-type="bibr">44</xref>]. Fig 5A shows the module clustering tree for the first block as an example. Fig 5B depicts the co-expression heatmap for the small module 2, in which a set of six genes display highly correlated expression patterns. Fig 5C contains the top 25% (in this case five) most interconnected genes from the small module 2, with module interconnectivity scores.</p>
        </caption>
        <graphic xlink:href="pcbi.1007665.g005"/>
      </fig>
      <p>Lastly, to evaluate whether the variables found to partition BC subtypes were predicted to interact, we used the pipeline to generate protein-protein interaction networks. <xref ref-type="fig" rid="pcbi.1007665.g006">Fig 6</xref> shows the top 100 strongest gene-gene interactions based on absolute logFC, and interaction score for the comparison of Her2-enriched vs Luminal A, as an example. Results for comparison of all subtypes pairwise may be found in the <italic>GitHub repository (CS1</italic>.<italic>zip)</italic>. From the plot in <xref ref-type="fig" rid="pcbi.1007665.g006">Fig 6</xref>, the two most interconnected genes in the contrast of Her2-enriched vs Luminal A samples, were ERBB2 and ESR1 (Estrogen Receptor 1). As expected, ERBB2 was highly up-regulated, while ESR1 was down-regulated in this comparison. Collectively, results highlight the utility of the complementary R-frameworks implemented in the CAMPP wrapper.</p>
      <fig id="pcbi.1007665.g006" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.g006</object-id>
        <label>Fig 6</label>
        <caption>
          <title>Plot showing the top 100 best protein-protein (gene-gene) interaction pairs from the analysis of HER2-enriched vs Luminal A samples.</title>
          <p>Colors denote the log fold change of a gene; yellow = up-regulated and blue = down-regulated. The size of the node shows the absolute log fold change, while the ordering from left to right denotes the degree of node interconnectivity. The width of the arch represents the interaction score from the STRING database.</p>
        </caption>
        <graphic xlink:href="pcbi.1007665.g006"/>
      </fig>
    </sec>
    <sec id="sec016">
      <title>Case Study 2</title>
      <p>Analysis of N-glycans from LC Tandem Mass Spectrometry—Clustering, Tissue-Serum Correlation and, Survival Analysis</p>
      <p>For case study 2, we analyzed quantitative N-glycan data from liquid-chromatography tandem mass spectrometry (LC-MS/MS). N-glycan abundances have been quantified from tumor and normal interstitial fluids (TIFs and NIFs). In addition to interstitial fluids, we had paired serum samples, enabling us to perform TIF-serum N-glycan abundance correlation analysis with CAMPP. We have published the results of the in-depth analysis of these data here; [<xref rid="pcbi.1007665.ref067" ref-type="bibr">67</xref>]. Before differential abundance analysis, we used the pipeline to perform K-means clustering of the samples. When running K-means with CAMPP, the user may specify labels to add to the MDS plots generated, to see which clinical variables, if any, best explain the observed clusters. From the evaluation of all k-means plot, the best number of clusters appeared to be two, one corresponding to tumor samples and one to normal samples. <xref ref-type="supplementary-material" rid="pcbi.1007665.s001">S1 Fig</xref> shows the two clusters with labels.</p>
      <p>After clustering analysis, we performed DAA and elastic-net regression, as described in the section on variable selection and in Case Study 1. Cut-off for FDR &lt; 0.05 and for elastic-net regression alpha was set to = 0.5. DAA yielded a total of 20 N-glycan groups (12 up-regulated in cancer vs normal and eight down-regulated in cancer vs. normal), while elastic-net returned six N-glycan groups, all encompassed by the DA set—results may be found in the GitHub repository <italic>(i</italic>.<italic>e</italic>., <italic>CS2</italic>.<italic>zip)</italic>. Serum correlation analysis and survival analysis were performed on the set of DE N-glycans. <xref ref-type="fig" rid="pcbi.1007665.g007">Fig 7</xref> shows the results of the correlation analysis with paired N-glycan abundances from TIFs and serum. Three N-glycan groups, GP1, GP37, and GP38 were found to displayed significant correlation scores after correction for multiple testing. <xref ref-type="fig" rid="pcbi.1007665.g007">Fig 7A</xref> shows correlation scores of all tested N-glycans, while 7B shows the individual scatter plots produced for the three significant N-glycan groups. Lastly, Cox proportional hazard regression was performed with correction for age at diagnosis as well as immune scores, as immune infiltration has been shown to be associated with patient response to treatment and survival [<xref rid="pcbi.1007665.ref068" ref-type="bibr">68</xref>]. <xref ref-type="fig" rid="pcbi.1007665.g008">Fig 8</xref> shows the hazard ratios for the DA N-glycan groups with confidence intervals. As seen from the figure, one N-glycan group, GP38, was significantly associated with overall survival, e.g., a high level of TIF GP38 was predictive of a poor patient outcome.</p>
      <fig id="pcbi.1007665.g007" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.g007</object-id>
        <label>Fig 7</label>
        <caption>
          <title>Results of correlation analysis with N-glycan abundances in interstitial fluids and paired serum samples.</title>
          <p>Dataset contained a total of 103 samples (51 normal interstitial fluids and 52 tumor interstitial fluids) with ~70 N-glycan groups (165 N-glycans). Fig 7A shows the correlation scores for differentially abundant N-glycan groups, three of these, GP1, GP37, and GP38 met the requirement for significance (corr &gt; 0.5 and fdr &lt; 0.05), y-axis = Spearman correlation coefficient. Fig 7B shows the individual correlation plots for the three significant N-glycan groups, x-axis = tumor interstitial fluid abundance and y-axis = serum abundance.</p>
        </caption>
        <graphic xlink:href="pcbi.1007665.g007"/>
      </fig>
      <fig id="pcbi.1007665.g008" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.g008</object-id>
        <label>Fig 8</label>
        <caption>
          <title>Results of survival analysis (cox-proportional hazard regression) with correction for patient age at diagnosis and tumor infiltrating lymphocyte status (TILs).</title>
          <p>Survival analysis was run on the set of differentially expressed N-glycan groups. Only one N-glycan, GP38, was significant after correction for multiple testing. Hazard ratios are displayed on a log2 scale with confidence intervals, x-axis = N-glycan groups, and y-axis = log2 hazard ratio.</p>
        </caption>
        <graphic xlink:href="pcbi.1007665.g008"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec017">
    <title>Discussion</title>
    <p>The CAMPP pipeline supports different types of analysis and will provide the user with graphics to support results—all plots displayed in this publication were generated with CAMPP with no or very minimal editing. CAMPP is implemented in such a way that a user is able to run the pipeline on their local computer on datasets with up to 300–500 samples and 40.000 variables. As an example of this, the user manual, (<ext-link ext-link-type="uri" xlink:href="https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP/blob/master/CAMPPManual.pdf">https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP/blob/master/CAMPPManual.pdf</ext-link>) includes the analysis of breast cancer RNA-seq data from TCGA (416 samples and ~ 32.000 gene transcripts, after filtering). For larger datasets, CAMPP may become slow and memory consuming if WGCNA is performed. In this case, it is advisable to run the pipeline on a server, allocating more cores—<xref rid="pcbi.1007665.t002" ref-type="table">Table 2</xref> shows run time, and memory use by CAMPP applied to datasets of different sizes.</p>
    <table-wrap id="pcbi.1007665.t002" orientation="portrait" position="float">
      <object-id pub-id-type="doi">10.1371/journal.pcbi.1007665.t002</object-id>
      <label>Table 2</label>
      <caption>
        <title>Table showing run times and memory usage for CAMPP applied to datasets of different sizes.</title>
        <p>As the weighted gene co-expression network analysis (WGCNA) and estimation of optimal number of clusters for k-means are by far the slowest and most memory consuming processes, we have provided estimates with and without these two analyses. The [.] denotes that a given analysis was not performed on a dataset.</p>
      </caption>
      <alternatives>
        <graphic id="pcbi.1007665.t002g" xlink:href="pcbi.1007665.t002"/>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1"/>
              <th align="left" rowspan="1" colspan="1">Type of Data</th>
              <th align="left" rowspan="1" colspan="1">Biological Type</th>
              <th align="left" rowspan="1" colspan="1">Number of Samples</th>
              <th align="left" rowspan="1" colspan="1">Number of Variables</th>
              <th align="left" rowspan="1" colspan="1">WGCNA Variables</th>
              <th align="left" rowspan="1" colspan="1">K-means</th>
              <th align="left" rowspan="1" colspan="1">Interaction Networks</th>
              <th align="left" rowspan="1" colspan="1">Run Time in Minutes</th>
              <th align="left" rowspan="1" colspan="1">Memory Usage in GB</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 1</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Mass Spectrometry</td>
              <td align="left" rowspan="1" colspan="1">N-glycans</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">165</td>
              <td align="left" rowspan="1" colspan="1">All</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">0,3</td>
              <td align="right" rowspan="1" colspan="1">0,6</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 2</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">15000</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">0,8</td>
              <td align="right" rowspan="1" colspan="1">0,8</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 2</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">15000</td>
              <td align="left" rowspan="1" colspan="1">Differentially Expressed</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">3,3</td>
              <td align="right" rowspan="1" colspan="1">1,4</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 2</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">15000</td>
              <td align="left" rowspan="1" colspan="1">All</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">12</td>
              <td align="right" rowspan="1" colspan="1">7,8</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 2</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">15000</td>
              <td align="left" rowspan="1" colspan="1">All</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">15,5</td>
              <td align="right" rowspan="1" colspan="1">7,8</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 3</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array + Array</td>
              <td align="left" rowspan="1" colspan="1">microRNA + mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">15754</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="right" rowspan="1" colspan="1">4</td>
              <td align="right" rowspan="1" colspan="1">1,6</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 3</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array + Array</td>
              <td align="left" rowspan="1" colspan="1">microRNA + mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">15754</td>
              <td align="left" rowspan="1" colspan="1">Differentially Expressed</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="right" rowspan="1" colspan="1">5,6</td>
              <td align="right" rowspan="1" colspan="1">1,6</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 3</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array + Array</td>
              <td align="left" rowspan="1" colspan="1">microRNA + mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">15754</td>
              <td align="left" rowspan="1" colspan="1">All</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="right" rowspan="1" colspan="1">16</td>
              <td align="right" rowspan="1" colspan="1">7,8</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 4</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">29274</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">1,2</td>
              <td align="right" rowspan="1" colspan="1">0,9</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 4</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Array</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">80</td>
              <td align="right" rowspan="1" colspan="1">29274</td>
              <td align="left" rowspan="1" colspan="1">Differentially Expressed</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">3,8</td>
              <td align="right" rowspan="1" colspan="1">1,9</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 5</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Sequencing</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">416</td>
              <td align="right" rowspan="1" colspan="1">55150</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">3</td>
              <td align="right" rowspan="1" colspan="1">1,5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 5</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Sequencing</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">416</td>
              <td align="right" rowspan="1" colspan="1">55150</td>
              <td align="left" rowspan="1" colspan="1">Differentially Expressed</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">3,5</td>
              <td align="right" rowspan="1" colspan="1">1,4</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Dataset 5</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Sequencing</td>
              <td align="left" rowspan="1" colspan="1">mRNA</td>
              <td align="right" rowspan="1" colspan="1">416</td>
              <td align="right" rowspan="1" colspan="1">55150</td>
              <td align="left" rowspan="1" colspan="1">Differentially Expressed</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">.</td>
              <td align="right" rowspan="1" colspan="1">12,8</td>
              <td align="right" rowspan="1" colspan="1">2,3</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
    </table-wrap>
    <p>We compared the pipeline to other open-source tools for throughput data analysis, found to have similar functionalities and user demographics. <xref ref-type="supplementary-material" rid="pcbi.1007665.s002">S1 Table</xref> shows a summary of the CAncer bioMarker Prediction Pipeline (CAMPP), alongside a selection of other software [<xref rid="pcbi.1007665.ref069" ref-type="bibr">69</xref>–<xref rid="pcbi.1007665.ref079" ref-type="bibr">79</xref>]. As seen from this comparison the strengths of CAMPP lie both in (I) the variety of analysis it can perform, (II) that the pipeline is able to handle different types of quantitative biological data, from different platforms and (III) that it is flexible in terms of modeling co-variates. Also, unlike most of the other tools, CAMPP employs <italic>limma</italic> for DE analysis. One advantage of <italic>limma</italic> is that this software has been shown to perform well even with very small sample sizes [<xref rid="pcbi.1007665.ref017" ref-type="bibr">17</xref>,<xref rid="pcbi.1007665.ref040" ref-type="bibr">40</xref>,<xref rid="pcbi.1007665.ref080" ref-type="bibr">80</xref>], a low power scenario that is not unfamiliar in biomedical research. Lastly, the pipeline is relatively fast to run even with larger gene expression datasets and somewhat robust to different operating systems as it relies on R/Rstudio, which are continuously maintained to follow system updates.</p>
    <p>We have tried to ensure that the software is user-friendly to those without much programming experience. However, we aware that this tool requires the user to work in a terminal environment and to have R and command-line tools installed on their computer. As such, this pipeline is targeted towards bioinformatic software users and computational-inclined bio-researchers.</p>
    <p>In summary, CAMPP is an R-based command-line tool for downstream analysis of high throughput biological data. CAMPP was developed with the intent to provide the biomedical community with an automated way of screening for biomolecules of interest while ensuring a standardized framework for data normalization and statistical analysis.</p>
  </sec>
  <sec id="sec018">
    <title>Availability and future directions</title>
    <p>The CAncer bioMarker Prediction Pipeline (CAMPP) is open source and may be downloaded from the github repository: <ext-link ext-link-type="uri" xlink:href="https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP">https://github.com/ELELAB/CAncer-bioMarker-Prediction-Pipeline-CAMPP</ext-link>.</p>
    <p>As it may be of interest for CAMPP users to understand in detail, how the underlying code and functions work, our plan for the future is to include an R-markdown code run-though. This way the code may more easily be copied and modified and improved, hopefully for the benefit of the computational biology community and for the pipeline itself, as code suggestions and revisions are welcome.</p>
  </sec>
  <sec sec-type="supplementary-material" id="sec019">
    <title>Supporting information</title>
    <supplementary-material content-type="local-data" id="pcbi.1007665.s001">
      <label>S1 Fig</label>
      <caption>
        <title>Multidimensional scaling plot.</title>
        <p>Plot showing the result of k-means clustering with k = 2. The two clusters support the presumed difference between N-glycan abundances in normal interstitial fluid vs tumor interstitial fluid samples.</p>
        <p>(PDF)</p>
      </caption>
      <media xlink:href="pcbi.1007665.s001.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="pcbi.1007665.s002">
      <label>S1 Table</label>
      <caption>
        <title>Comparison of the CAncer bioMarker Prediction Pipeline (CAMPP) with other tools for high-throughput data analysis.</title>
        <p>This table includes a detailed comparison of the analyses and tools implemented in CAMPP with respect to other bioinformatic resources available.</p>
        <p>(XLSX)</p>
      </caption>
      <media xlink:href="pcbi.1007665.s002.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <p>The authors would like to thank Vendela Rissler and Emiliano Maiani for testing CAMPP and for helping us with debugging. The calculations described in this paper were performed using the DeiC National Life Science Supercomputer at DTU.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="pcbi.1007665.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Dai</surname><given-names>X</given-names></name>, <name><surname>Xiang</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Bai</surname><given-names>Z</given-names></name>. <article-title>Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes</article-title>. <source>J Cancer</source>. <year>2016</year>;<volume>7</volume>(<issue>10</issue>):<fpage>1281</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.7150/jca.13141</pub-id><?supplied-pmid 27390604?><pub-id pub-id-type="pmid">27390604</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Duffy</surname><given-names>MJ</given-names></name>, <name><surname>Harbeck</surname><given-names>N</given-names></name>, <name><surname>Nap</surname><given-names>M</given-names></name>, <name><surname>Molina</surname><given-names>R</given-names></name>, <name><surname>Nicolini</surname><given-names>A</given-names></name>, <name><surname>Senkus</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)</article-title>. <source>Eur J Cancer</source>. <year>2017</year>;<volume>75</volume>:<fpage>284</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejca.2017.01.017</pub-id><?supplied-pmid 28259011?><pub-id pub-id-type="pmid">28259011</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>La Thangue</surname><given-names>NB</given-names></name>, <name><surname>Kerr</surname><given-names>DJ</given-names></name>. <article-title>Predictive biomarkers: a paradigm shift towards personalized cancer medicine</article-title>. <source>Nat Rev Clin Oncol</source>. <year>2011</year>;<volume>8</volume>(<issue>10</issue>):<fpage>587</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1038/nrclinonc.2011.121</pub-id><?supplied-pmid 21862978?><pub-id pub-id-type="pmid">21862978</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Vieira</surname><given-names>AF</given-names></name>, <name><surname>Schmitt</surname><given-names>F</given-names></name>. <article-title>An Update on Breast Cancer Multigene Prognostic Tests-Emergent Clinical Biomarkers</article-title>. <source>Front Med (Lausanne)</source>. <year>2018</year>;<volume>5</volume>:<fpage>248</fpage>.<pub-id pub-id-type="pmid">30234119</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Yotsukura</surname><given-names>S</given-names></name>, <name><surname>Mamitsuka</surname><given-names>H</given-names></name>. <article-title>Evaluation of serum-based cancer biomarkers: a brief review from a clinical and computational viewpoint</article-title>. <source>Crit Rev Oncol Hematol</source>. <year>2015</year>;<volume>93</volume>(<issue>2</issue>):<fpage>103</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.critrevonc.2014.10.002</pub-id><?supplied-pmid 25459666?><pub-id pub-id-type="pmid">25459666</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Kern</surname><given-names>SE</given-names></name>. <article-title>Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures</article-title>. <source>Cancer Res</source>. <year>2012</year>;<volume>72</volume>(<issue>23</issue>):<fpage>6097</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-3232</pub-id><?supplied-pmid 23172309?><pub-id pub-id-type="pmid">23172309</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Tiberio</surname><given-names>P</given-names></name>, <name><surname>Callari</surname><given-names>M</given-names></name>, <name><surname>Angeloni</surname><given-names>V</given-names></name>, <name><surname>Daidone</surname><given-names>MG</given-names></name>, <name><surname>Appierto</surname><given-names>V</given-names></name>. <article-title>Challenges in using circulating miRNAs as cancer biomarkers</article-title>. <source>Biomed Res Int</source>. <year>2015</year>;<volume>2015</volume>:<fpage>731479</fpage><pub-id pub-id-type="doi">10.1155/2015/731479</pub-id><?supplied-pmid 25874226?><pub-id pub-id-type="pmid">25874226</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>Ioannidis</surname><given-names>JP</given-names></name>, <name><surname>Allison</surname><given-names>DB</given-names></name>, <name><surname>Ball</surname><given-names>CA</given-names></name>, <name><surname>Coulibaly</surname><given-names>I</given-names></name>, <name><surname>Cui</surname><given-names>X</given-names></name>, <name><surname>Culhane</surname><given-names>AC</given-names></name>, <etal>et al</etal><article-title>Repeatability of published microarray gene expression analyses</article-title>. <source>Nat Genet</source>. <year>2009</year>;<volume>41</volume>(<issue>2</issue>):<fpage>149</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/ng.295</pub-id><?supplied-pmid 19174838?><pub-id pub-id-type="pmid">19174838</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Berghuis</surname><given-names>AMS</given-names></name>, <name><surname>Koffijberg</surname><given-names>H</given-names></name>, <name><surname>Prakash</surname><given-names>J</given-names></name>, <name><surname>Terstappen</surname><given-names>LW</given-names></name>, <name><surname>MJ</surname><given-names>IJ</given-names></name>. <article-title>Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility</article-title>. <source>Int J Mol Sci</source>. <year>2017</year>;<volume>18</volume>(<issue>2</issue>):<fpage>363</fpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Nicolle</surname><given-names>R</given-names></name>, <name><surname>Raffenne</surname><given-names>J</given-names></name>, <name><surname>Paradis</surname><given-names>V</given-names></name>, <name><surname>Couvelard</surname><given-names>A</given-names></name>, <name><surname>de Reynies</surname><given-names>A</given-names></name>, <name><surname>Blum</surname><given-names>Y</given-names></name>, <etal>et al</etal><article-title>Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset</article-title>. <source>Cancers (Basel)</source>. <year>2019</year>;<volume>11</volume>(<issue>1</issue>):<fpage>126</fpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Minciacchi</surname><given-names>VR</given-names></name>, <name><surname>Zijlstra</surname><given-names>A</given-names></name>, <name><surname>Rubin</surname><given-names>MA</given-names></name>, <name><surname>Di Vizio</surname><given-names>D</given-names></name>. <article-title>Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed</article-title>? <source>Prostate Cancer Prostatic Dis</source>. <year>2017</year>;<volume>20</volume>(<issue>3</issue>):<fpage>251</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/pcan.2017.7</pub-id><?supplied-pmid 28374743?><pub-id pub-id-type="pmid">28374743</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Ghosh</surname><given-names>D</given-names></name>, <name><surname>Poisson</surname><given-names>LM</given-names></name>. <article-title>"Omics" data and levels of evidence for biomarker discovery</article-title>. <source>Genomics</source>. <year>2009</year>;<volume>93</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2008.07.006</pub-id><?supplied-pmid 18723089?><pub-id pub-id-type="pmid">18723089</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Merrick</surname><given-names>BA</given-names></name>, <name><surname>London</surname><given-names>RE</given-names></name>, <name><surname>Bushel</surname><given-names>PR</given-names></name>, <name><surname>Grissom</surname><given-names>SF</given-names></name>, <name><surname>Paules</surname><given-names>RS</given-names></name>. <article-title>Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics</article-title>. <source>IARC Sci Publ</source>. <year>2011</year>(<issue>163</issue>):<fpage>121</fpage>–<lpage>42</lpage>. <?supplied-pmid 22997859?><pub-id pub-id-type="pmid">22997859</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Alcaraz</surname><given-names>N</given-names></name>, <name><surname>List</surname><given-names>M</given-names></name>, <name><surname>Batra</surname><given-names>R</given-names></name>, <name><surname>Vandin</surname><given-names>F</given-names></name>, <name><surname>Ditzel</surname><given-names>HJ</given-names></name>, <name><surname>Baumbach</surname><given-names>J</given-names></name>. <article-title>De novo pathway-based biomarker identification</article-title>. <source>Nucleic Acids Res</source>. <year>2017</year>;<volume>45</volume>(<issue>16</issue>):<fpage>e151</fpage><pub-id pub-id-type="doi">10.1093/nar/gkx642</pub-id><?supplied-pmid 28934488?><pub-id pub-id-type="pmid">28934488</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Papaleo</surname><given-names>E</given-names></name>, <name><surname>Gromova</surname><given-names>I</given-names></name>, <name><surname>Gromov</surname><given-names>P</given-names></name>. <article-title>Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools</article-title>. <source>Expert Rev Proteomics</source>. <year>2017</year>;<volume>14</volume>(<issue>11</issue>):<fpage>1021</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1080/14789450.2017.1387053</pub-id><?supplied-pmid 28967788?><pub-id pub-id-type="pmid">28967788</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>E</given-names></name>, <name><surname>Cho</surname><given-names>WCS</given-names></name>, <name><surname>Wong</surname><given-names>SCC</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>. <article-title>Disease Biomarkers for Precision Medicine: Challenges and Future Opportunities</article-title>. <source>Genomics Proteomics Bioinformatics</source>. <year>2017</year>;<volume>15</volume>(<issue>2</issue>):<fpage>57</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.gpb.2017.04.001</pub-id><?supplied-pmid 28392478?><pub-id pub-id-type="pmid">28392478</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Soneson</surname><given-names>C</given-names></name>, <name><surname>Delorenzi</surname><given-names>M</given-names></name>. <article-title>A comparison of methods for differential expression analysis of RNA-seq data</article-title>. <source>BMC Bioinformatics</source>. <year>2013</year>;<volume>14</volume>(<issue>1</issue>):<fpage>91</fpage>.<pub-id pub-id-type="pmid">23497356</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Swan</surname><given-names>AL</given-names></name>, <name><surname>Mobasheri</surname><given-names>A</given-names></name>, <name><surname>Allaway</surname><given-names>D</given-names></name>, <name><surname>Liddell</surname><given-names>S</given-names></name>, <name><surname>Bacardit</surname><given-names>J</given-names></name>. <article-title>Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biology</article-title>. <source>OMICS</source>. <year>2013</year>;<volume>17</volume>(<issue>12</issue>):<fpage>595</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2013.0017</pub-id><?supplied-pmid 24116388?><pub-id pub-id-type="pmid">24116388</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Kursa</surname><given-names>MB</given-names></name>. <article-title>Robustness of Random Forest-based gene selection methods</article-title>. <source>BMC Bioinformatics</source>. <year>2014</year>;<volume>15</volume>(<issue>1</issue>):<fpage>8</fpage>.<pub-id pub-id-type="pmid">24410865</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>HH</given-names></name>, <name><surname>Liu</surname><given-names>XY</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>. <article-title>Feature Selection and Cancer Classification via Sparse Logistic Regression with the Hybrid L1/2 +2 Regularization</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>5</issue>):<fpage>e0149675</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0149675</pub-id><?supplied-pmid 27136190?><pub-id pub-id-type="pmid">27136190</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Malta</surname><given-names>TM</given-names></name>, <name><surname>Sokolov</surname><given-names>A</given-names></name>, <name><surname>Gentles</surname><given-names>AJ</given-names></name>, <name><surname>Burzykowski</surname><given-names>T</given-names></name>, <name><surname>Poisson</surname><given-names>L</given-names></name>, <name><surname>Weinstein</surname><given-names>JN</given-names></name>, <etal>et al</etal><article-title>Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation</article-title>. <source>Cell</source>. <year>2018</year>;<volume>173</volume>(<issue>2</issue>):<fpage>338</fpage>–<lpage>54</lpage> e15. <pub-id pub-id-type="doi">10.1016/j.cell.2018.03.034</pub-id>
<?supplied-pmid 29625051?><pub-id pub-id-type="pmid">29625051</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>McDermott</surname><given-names>JE</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Mitchell</surname><given-names>H</given-names></name>, <name><surname>Webb-Robertson</surname><given-names>BJ</given-names></name>, <name><surname>Hafen</surname><given-names>R</given-names></name>, <name><surname>Ramey</surname><given-names>J</given-names></name>, <etal>et al</etal><article-title>Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data</article-title>. <source>Expert Opin Med Diagn</source>. <year>2013</year>;<volume>7</volume>(<issue>1</issue>):<fpage>37</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1517/17530059.2012.718329</pub-id><?supplied-pmid 23335946?><pub-id pub-id-type="pmid">23335946</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Qin</surname><given-names>LX</given-names></name>, <name><surname>Levine</surname><given-names>DA</given-names></name>. <article-title>Study design and data analysis considerations for the discovery of prognostic molecular biomarkers: a case study of progression free survival in advanced serous ovarian cancer</article-title>. <source>BMC Med Genomics</source>. <year>2016</year>;<volume>9</volume>(<issue>1</issue>):<fpage>27</fpage><pub-id pub-id-type="doi">10.1186/s12920-016-0187-4</pub-id><?supplied-pmid 27282150?><pub-id pub-id-type="pmid">27282150</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Siu</surname><given-names>LL</given-names></name>, <name><surname>Lawler</surname><given-names>M</given-names></name>, <name><surname>Haussler</surname><given-names>D</given-names></name>, <name><surname>Knoppers</surname><given-names>BM</given-names></name>, <name><surname>Lewin</surname><given-names>J</given-names></name>, <name><surname>Vis</surname><given-names>DJ</given-names></name>, <etal>et al</etal><article-title>Facilitating a culture of responsible and effective sharing of cancer genome data</article-title>. <source>Nat Med</source>. <year>2016</year>;<volume>22</volume>(<issue>5</issue>):<fpage>464</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4089</pub-id><?supplied-pmid 27149219?><pub-id pub-id-type="pmid">27149219</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>J</given-names></name>, <name><surname>Lieberman</surname><given-names>JA</given-names></name>, <name><surname>Lockwood</surname><given-names>CM</given-names></name>. <article-title>Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs</article-title>. <source>Clin Chem Lab Med</source>. <year>2017</year>;<volume>55</volume>(<issue>5</issue>):<fpage>608</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2016-0471</pub-id><?supplied-pmid 28306519?><pub-id pub-id-type="pmid">28306519</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Witwer</surname><given-names>KW</given-names></name>. <article-title>Circulating microRNA biomarker studies: pitfalls and potential solutions</article-title>. <source>Clin Chem</source>. <year>2015</year>;<volume>61</volume>(<issue>1</issue>):<fpage>56</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1373/clinchem.2014.221341</pub-id><?supplied-pmid 25391989?><pub-id pub-id-type="pmid">25391989</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>List</surname><given-names>M</given-names></name>, <name><surname>Ebert</surname><given-names>P</given-names></name>, <name><surname>Albrecht</surname><given-names>F</given-names></name>. <article-title>Ten Simple Rules for Developing Usable Software in Computational Biology</article-title>. <source>PLoS Comput Biol</source>. <year>2017</year>;<volume>13</volume>(<issue>1</issue>):<fpage>e1005265</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005265</pub-id><?supplied-pmid 28056032?><pub-id pub-id-type="pmid">28056032</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref028">
      <label>28</label>
      <mixed-citation publication-type="other">Ushey K. renv: Project Environments. R package version 0.8.3 ed2019.</mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Stacklies</surname><given-names>W</given-names></name>, <name><surname>Redestig</surname><given-names>H</given-names></name>, <name><surname>Scholz</surname><given-names>M</given-names></name>, <name><surname>Walther</surname><given-names>D</given-names></name>, <name><surname>Selbig</surname><given-names>J</given-names></name>. <article-title>pcaMethods—a bioconductor package providing PCA methods for incomplete data</article-title>. <source>Bioinformatics</source>. <year>2007</year>;<volume>23</volume>(<issue>9</issue>):<fpage>1164</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btm069</pub-id><?supplied-pmid 17344241?><pub-id pub-id-type="pmid">17344241</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref030">
      <label>30</label>
      <mixed-citation publication-type="journal"><name><surname>Hastie</surname><given-names>T</given-names></name>, <name><surname>Tibshirani</surname><given-names>R</given-names></name>, <name><surname>Narasimhan</surname><given-names>B</given-names></name>, <name><surname>Chu</surname><given-names>G</given-names></name>. <source>Impute: Imputation for microarray data</source>. <year>2018</year>.</mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref031">
      <label>31</label>
      <mixed-citation publication-type="journal"><name><surname>Celton</surname><given-names>M</given-names></name>, <name><surname>Malpertuy</surname><given-names>A</given-names></name>, <name><surname>Lelandais</surname><given-names>G</given-names></name>, <name><surname>de Brevern</surname><given-names>AG</given-names></name>. <article-title>Comparative analysis of missing value imputation methods to improve clustering and interpretation of microarray experiments</article-title>. <source>BMC Genomics</source>. <year>2010</year>;<volume>11</volume>(<issue>1</issue>):<fpage>15</fpage>.<pub-id pub-id-type="pmid">20056002</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref032">
      <label>32</label>
      <mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name>, <name><surname>Oshlack</surname><given-names>A</given-names></name>. <article-title>A scaling normalization method for differential expression analysis of RNA-seq data</article-title>. <source>Genome Biol</source>. <year>2010</year>;<volume>11</volume>(<issue>3</issue>):<fpage>R25</fpage><pub-id pub-id-type="doi">10.1186/gb-2010-11-3-r25</pub-id><?supplied-pmid 20196867?><pub-id pub-id-type="pmid">20196867</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref033">
      <label>33</label>
      <mixed-citation publication-type="journal"><name><surname>Bolstad</surname><given-names>BM</given-names></name>, <name><surname>Irizarry</surname><given-names>RA</given-names></name>, <name><surname>Astrand</surname><given-names>M</given-names></name>, <name><surname>Speed</surname><given-names>TP</given-names></name>. <article-title>A comparison of normalization methods for high density oligonucleotide array data based on variance and bias</article-title>. <source>Bioinformatics</source>. <year>2003</year>;<volume>19</volume>(<issue>2</issue>):<fpage>185</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/19.2.185</pub-id><?supplied-pmid 12538238?><pub-id pub-id-type="pmid">12538238</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref034">
      <label>34</label>
      <mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>J</given-names></name>, <name><surname>Schumacher</surname><given-names>M</given-names></name>, <name><surname>Scherer</surname><given-names>A</given-names></name>, <name><surname>Sanoudou</surname><given-names>D</given-names></name>, <name><surname>Megherbi</surname><given-names>D</given-names></name>, <name><surname>Davison</surname><given-names>T</given-names></name>, <etal>et al</etal><article-title>A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data</article-title>. <source>Pharmacogenomics J</source>. <year>2010</year>;<volume>10</volume>(<issue>4</issue>):<fpage>278</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/tpj.2010.57</pub-id><?supplied-pmid 20676067?><pub-id pub-id-type="pmid">20676067</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref035">
      <label>35</label>
      <mixed-citation publication-type="journal"><name><surname>Delignette-Muller</surname><given-names>ML</given-names></name>, <name><surname>Christophe</surname><given-names>D</given-names></name>. <article-title>fitdistrplus: An R package for fitting distributions</article-title>. <source>Journal of Statistical Software</source>. <year>2015</year>(<issue>64.4</issue>):<fpage>1</fpage>–<lpage>34</lpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref036">
      <label>36</label>
      <mixed-citation publication-type="journal"><name><surname>Scrucca</surname><given-names>L</given-names></name>, <name><surname>Fop</surname><given-names>M</given-names></name>, <name><surname>Murphy</surname><given-names>TB</given-names></name>, <name><surname>Raftery</surname><given-names>AE</given-names></name>. <article-title>mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models</article-title>. <source>R J</source>. <year>2016</year>;<volume>8</volume>(<issue>1</issue>):<fpage>289</fpage>–<lpage>317</lpage>. <?supplied-pmid 27818791?><pub-id pub-id-type="pmid">27818791</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref037">
      <label>37</label>
      <mixed-citation publication-type="journal"><name><surname>Ritchie</surname><given-names>ME</given-names></name>, <name><surname>Phipson</surname><given-names>B</given-names></name>, <name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Law</surname><given-names>CW</given-names></name>, <name><surname>Shi</surname><given-names>W</given-names></name>, <etal>et al</etal><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source>. <year>2015</year>;<volume>43</volume>(<issue>7</issue>):<fpage>e47</fpage><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><?supplied-pmid 25605792?><pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref038">
      <label>38</label>
      <mixed-citation publication-type="journal"><name><surname>Kammers</surname><given-names>K</given-names></name>, <name><surname>Cole</surname><given-names>RN</given-names></name>, <name><surname>Tiengwe</surname><given-names>C</given-names></name>, <name><surname>Ruczinski</surname><given-names>I</given-names></name>. <article-title>Detecting Significant Changes in Protein Abundance</article-title>. <source>EuPA Open Proteom</source>. <year>2015</year>;<volume>7</volume>:<fpage>11</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.euprot.2015.02.002</pub-id><?supplied-pmid 25821719?><pub-id pub-id-type="pmid">25821719</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref039">
      <label>39</label>
      <mixed-citation publication-type="journal"><name><surname>van Ooijen</surname><given-names>MP</given-names></name>, <name><surname>Jong</surname><given-names>VL</given-names></name>, <name><surname>Eijkemans</surname><given-names>MJC</given-names></name>, <name><surname>Heck</surname><given-names>AJR</given-names></name>, <name><surname>Andeweg</surname><given-names>AC</given-names></name>, <name><surname>Binai</surname><given-names>NA</given-names></name>, <etal>et al</etal><article-title>Identification of differentially expressed peptides in high-throughput proteomics data</article-title>. <source>Brief Bioinform</source>. <year>2018</year>;<volume>19</volume>(<issue>5</issue>):<fpage>971</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbx031</pub-id><?supplied-pmid 28369175?><pub-id pub-id-type="pmid">28369175</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref040">
      <label>40</label>
      <mixed-citation publication-type="journal"><name><surname>Seyednasrollah</surname><given-names>F</given-names></name>, <name><surname>Laiho</surname><given-names>A</given-names></name>, <name><surname>Elo</surname><given-names>LL</given-names></name>. <article-title>Comparison of software packages for detecting differential expression in RNA-seq studies</article-title>. <source>Brief Bioinform</source>. <year>2015</year>;<volume>16</volume>(<issue>1</issue>):<fpage>59</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbt086</pub-id><?supplied-pmid 24300110?><pub-id pub-id-type="pmid">24300110</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref041">
      <label>41</label>
      <mixed-citation publication-type="journal"><name><surname>Leek</surname><given-names>JT</given-names></name>, <name><surname>Storey</surname><given-names>JD</given-names></name>. <article-title>Capturing heterogeneity in gene expression studies by surrogate variable analysis</article-title>. <source>PLoS Genet</source>. <year>2007</year>;<volume>3</volume>(<issue>9</issue>):<fpage>1724</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030161</pub-id><?supplied-pmid 17907809?><pub-id pub-id-type="pmid">17907809</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref042">
      <label>42</label>
      <mixed-citation publication-type="journal"><name><surname>Friedman</surname><given-names>J</given-names></name>, <name><surname>Hastie</surname><given-names>T</given-names></name>, <name><surname>Tibshirani</surname><given-names>R</given-names></name>. <article-title>Regularization Paths for Generalized Linear Models via Coordinate Descent</article-title>. <source>J Stat Softw</source>. <year>2010</year>;<volume>33</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>22</lpage>. <?supplied-pmid 20808728?><pub-id pub-id-type="pmid">20808728</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref043">
      <label>43</label>
      <mixed-citation publication-type="journal"><name><surname>Robin</surname><given-names>X</given-names></name>, <name><surname>Turck</surname><given-names>N</given-names></name>, <name><surname>Hainard</surname><given-names>A</given-names></name>, <name><surname>Tiberti</surname><given-names>N</given-names></name>, <name><surname>Lisacek</surname><given-names>F</given-names></name>, <name><surname>Sanchez</surname><given-names>JC</given-names></name>, <etal>et al</etal><article-title>pROC: an open-source package for R and S+ to analyze and compare ROC curves</article-title>. <source>BMC Bioinformatics</source>. <year>2011</year>;<volume>12</volume>:<fpage>77</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-12-77</pub-id><?supplied-pmid 21414208?><pub-id pub-id-type="pmid">21414208</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref044">
      <label>44</label>
      <mixed-citation publication-type="journal"><name><surname>Langfelder</surname><given-names>P</given-names></name>, <name><surname>Horvath</surname><given-names>S</given-names></name>. <article-title>WGCNA: an R package for weighted correlation network analysis</article-title>. <source>BMC Bioinformatics</source>. <year>2008</year>;<volume>9</volume>:<fpage>559</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id><?supplied-pmid 19114008?><pub-id pub-id-type="pmid">19114008</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref045">
      <label>45</label>
      <mixed-citation publication-type="journal"><name><surname>Schroder</surname><given-names>MS</given-names></name>, <name><surname>Culhane</surname><given-names>AC</given-names></name>, <name><surname>Quackenbush</surname><given-names>J</given-names></name>, <name><surname>Haibe-Kains</surname><given-names>B</given-names></name>. <article-title>survcomp: an R/Bioconductor package for performance assessment and comparison of survival models</article-title>. <source>Bioinformatics</source>. <year>2011</year>;<volume>27</volume>(<issue>22</issue>):<fpage>3206</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr511</pub-id><?supplied-pmid 21903630?><pub-id pub-id-type="pmid">21903630</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref046">
      <label>46</label>
      <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Lichtenberg</surname><given-names>T</given-names></name>, <name><surname>Hoadley</surname><given-names>KA</given-names></name>, <name><surname>Poisson</surname><given-names>LM</given-names></name>, <name><surname>Lazar</surname><given-names>AJ</given-names></name>, <name><surname>Cherniack</surname><given-names>AD</given-names></name>, <etal>et al</etal><article-title>An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics</article-title>. <source>Cell</source>. <year>2018</year>;<volume>173</volume>(<issue>2</issue>):<fpage>400</fpage>–<lpage>16 e11</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.02.052</pub-id><?supplied-pmid 29625055?><pub-id pub-id-type="pmid">29625055</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref047">
      <label>47</label>
      <mixed-citation publication-type="journal"><name><surname>Jensen</surname><given-names>LJ</given-names></name>, <name><surname>Kuhn</surname><given-names>M</given-names></name>, <name><surname>Stark</surname><given-names>M</given-names></name>, <name><surname>Chaffron</surname><given-names>S</given-names></name>, <name><surname>Creevey</surname><given-names>C</given-names></name>, <name><surname>Muller</surname><given-names>J</given-names></name>, <etal>et al</etal><article-title>STRING 8—a global view on proteins and their functional interactions in 630 organisms</article-title>. <source>Nucleic Acids Res</source>. <year>2009</year>;<volume>37</volume>(Database issue):<fpage>D412</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn760</pub-id><?supplied-pmid 18940858?><pub-id pub-id-type="pmid">18940858</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref048">
      <label>48</label>
      <mixed-citation publication-type="journal"><name><surname>Chou</surname><given-names>CH</given-names></name>, <name><surname>Shrestha</surname><given-names>S</given-names></name>, <name><surname>Yang</surname><given-names>CD</given-names></name>, <name><surname>Chang</surname><given-names>NW</given-names></name>, <name><surname>Lin</surname><given-names>YL</given-names></name>, <name><surname>Liao</surname><given-names>KW</given-names></name>, <etal>et al</etal><article-title>miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year>;<volume>46</volume>(<issue>D1</issue>):<fpage>D296</fpage>–<lpage>D302</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1067</pub-id><?supplied-pmid 29126174?><pub-id pub-id-type="pmid">29126174</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref049">
      <label>49</label>
      <mixed-citation publication-type="journal"><name><surname>Agarwal</surname><given-names>V</given-names></name>, <name><surname>Bell</surname><given-names>GW</given-names></name>, <name><surname>Nam</surname><given-names>JW</given-names></name>, <name><surname>Bartel</surname><given-names>DP</given-names></name>. <article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>. <source>Elife</source>. <year>2015</year>;<volume>4</volume>:<fpage>e05005</fpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref050">
      <label>50</label>
      <mixed-citation publication-type="journal"><name><surname>Ru</surname><given-names>Y</given-names></name>, <name><surname>Kechris</surname><given-names>KJ</given-names></name>, <name><surname>Tabakoff</surname><given-names>B</given-names></name>, <name><surname>Hoffman</surname><given-names>P</given-names></name>, <name><surname>Radcliffe</surname><given-names>RA</given-names></name>, <name><surname>Bowler</surname><given-names>R</given-names></name>, <etal>et al</etal><article-title>The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations</article-title>. <source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>(<issue>17</issue>):<fpage>e133</fpage><pub-id pub-id-type="doi">10.1093/nar/gku631</pub-id><?supplied-pmid 25063298?><pub-id pub-id-type="pmid">25063298</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref051">
      <label>51</label>
      <mixed-citation publication-type="journal"><name><surname>Shannon</surname><given-names>P</given-names></name>, <name><surname>Markiel</surname><given-names>A</given-names></name>, <name><surname>Ozier</surname><given-names>O</given-names></name>, <name><surname>Baliga</surname><given-names>NS</given-names></name>, <name><surname>Wang</surname><given-names>JT</given-names></name>, <name><surname>Ramage</surname><given-names>D</given-names></name>, <etal>et al</etal><article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res</source>. <year>2003</year>;<volume>13</volume>(<issue>11</issue>):<fpage>2498</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><?supplied-pmid 14597658?><pub-id pub-id-type="pmid">14597658</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref052">
      <label>52</label>
      <mixed-citation publication-type="journal"><name><surname>Jabeen</surname><given-names>S</given-names></name>, <name><surname>Espinoza</surname><given-names>JA</given-names></name>, <name><surname>Torland</surname><given-names>LA</given-names></name>, <name><surname>Zucknick</surname><given-names>M</given-names></name>, <name><surname>Kumar</surname><given-names>S</given-names></name>, <name><surname>Haakensen</surname><given-names>VD</given-names></name>, <etal>et al</etal><article-title>Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics</article-title>. <source>Oncoimmunology</source>. <year>2019</year>;<volume>8</volume>(<issue>2</issue>):<fpage>e1537691</fpage><pub-id pub-id-type="doi">10.1080/2162402X.2018.1537691</pub-id><?supplied-pmid 30713794?><pub-id pub-id-type="pmid">30713794</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref053">
      <label>53</label>
      <mixed-citation publication-type="journal"><name><surname>Habashy</surname><given-names>HO</given-names></name>, <name><surname>Powe</surname><given-names>DG</given-names></name>, <name><surname>Glaab</surname><given-names>E</given-names></name>, <name><surname>Ball</surname><given-names>G</given-names></name>, <name><surname>Spiteri</surname><given-names>I</given-names></name>, <name><surname>Krasnogor</surname><given-names>N</given-names></name>, <etal>et al</etal><article-title>RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype</article-title>. <source>Breast Cancer Res Treat</source>. <year>2011</year>;<volume>128</volume>(<issue>2</issue>):<fpage>315</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s10549-010-1073-y</pub-id><?supplied-pmid 20697807?><pub-id pub-id-type="pmid">20697807</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref054">
      <label>54</label>
      <mixed-citation publication-type="journal"><name><surname>Rakha</surname><given-names>EA</given-names></name>, <name><surname>El-Sayed</surname><given-names>ME</given-names></name>, <name><surname>Green</surname><given-names>AR</given-names></name>, <name><surname>Paish</surname><given-names>EC</given-names></name>, <name><surname>Powe</surname><given-names>DG</given-names></name>, <name><surname>Gee</surname><given-names>J</given-names></name>, <etal>et al</etal><article-title>Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype</article-title>. <source>J Clin Oncol</source>. <year>2007</year>;<volume>25</volume>(<issue>30</issue>):<fpage>4772</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2007.12.2747</pub-id><?supplied-pmid 17876012?><pub-id pub-id-type="pmid">17876012</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref055">
      <label>55</label>
      <mixed-citation publication-type="journal"><name><surname>El-Gebali</surname><given-names>S</given-names></name>, <name><surname>Bentz</surname><given-names>S</given-names></name>, <name><surname>Hediger</surname><given-names>MA</given-names></name>, <name><surname>Anderle</surname><given-names>P</given-names></name>. <article-title>Solute carriers (SLCs) in cancer</article-title>. <source>Mol Aspects Med</source>. <year>2013</year>;<volume>34</volume>(<issue>2–3</issue>):<fpage>719</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2012.12.007</pub-id><?supplied-pmid 23506905?><pub-id pub-id-type="pmid">23506905</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref056">
      <label>56</label>
      <mixed-citation publication-type="journal"><name><surname>Yen</surname><given-names>MC</given-names></name>, <name><surname>Chou</surname><given-names>SK</given-names></name>, <name><surname>Kan</surname><given-names>JY</given-names></name>, <name><surname>Kuo</surname><given-names>PL</given-names></name>, <name><surname>Hou</surname><given-names>MF</given-names></name>, <name><surname>Hsu</surname><given-names>YL</given-names></name>. <article-title>Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells</article-title>. <source>Int J Mol Sci</source>. <year>2018</year>;<volume>19</volume>(<issue>11</issue>):<fpage>3434</fpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref057">
      <label>57</label>
      <mixed-citation publication-type="journal"><name><surname>Parker</surname><given-names>JS</given-names></name>, <name><surname>Mullins</surname><given-names>M</given-names></name>, <name><surname>Cheang</surname><given-names>MC</given-names></name>, <name><surname>Leung</surname><given-names>S</given-names></name>, <name><surname>Voduc</surname><given-names>D</given-names></name>, <name><surname>Vickery</surname><given-names>T</given-names></name>, <etal>et al</etal><article-title>Supervised risk predictor of breast cancer based on intrinsic subtypes</article-title>. <source>J Clin Oncol</source>. <year>2009</year>;<volume>27</volume>(<issue>8</issue>):<fpage>1160</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2008.18.1370</pub-id><?supplied-pmid 19204204?><pub-id pub-id-type="pmid">19204204</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref058">
      <label>58</label>
      <mixed-citation publication-type="journal"><name><surname>Su</surname><given-names>D</given-names></name>, <name><surname>Fu</surname><given-names>X</given-names></name>, <name><surname>Fan</surname><given-names>S</given-names></name>, <name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>XX</given-names></name>, <name><surname>Fu</surname><given-names>L</given-names></name>, <etal>et al</etal><article-title>Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells</article-title>. <source>Am J Pathol</source>. <year>2012</year>;<volume>180</volume>(<issue>3</issue>):<fpage>1189</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2011.11.025</pub-id><?supplied-pmid 22341523?><pub-id pub-id-type="pmid">22341523</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref059">
      <label>59</label>
      <mixed-citation publication-type="journal"><name><surname>Naderi</surname><given-names>A</given-names></name>. <article-title>C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer</article-title>. <source>Oncotarget</source>. <year>2017</year>;<volume>8</volume>(<issue>34</issue>):<fpage>57907</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.17826</pub-id><?supplied-pmid 28915724?><pub-id pub-id-type="pmid">28915724</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref060">
      <label>60</label>
      <mixed-citation publication-type="journal"><name><surname>Paculova</surname><given-names>H</given-names></name>, <name><surname>Kohoutek</surname><given-names>J</given-names></name>. <article-title>The emerging roles of CDK12 in tumorigenesis</article-title>. <source>Cell Div</source>. <year>2017</year>;<volume>12</volume>(<issue>1</issue>):<fpage>7</fpage>.<pub-id pub-id-type="pmid">29090014</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref061">
      <label>61</label>
      <mixed-citation publication-type="journal"><name><surname>Lo</surname><given-names>R</given-names></name>, <name><surname>Burgoon</surname><given-names>L</given-names></name>, <name><surname>Macpherson</surname><given-names>L</given-names></name>, <name><surname>Ahmed</surname><given-names>S</given-names></name>, <name><surname>Matthews</surname><given-names>J</given-names></name>. <article-title>Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells</article-title>. <source>Biochim Biophys Acta</source>. <year>2010</year>;<volume>1799</volume>(<issue>5–6</issue>):<fpage>469</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagrm.2010.01.005</pub-id><?supplied-pmid 20079471?><pub-id pub-id-type="pmid">20079471</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref062">
      <label>62</label>
      <mixed-citation publication-type="journal"><name><surname>D'Amato</surname><given-names>V</given-names></name>, <name><surname>Raimondo</surname><given-names>L</given-names></name>, <name><surname>Formisano</surname><given-names>L</given-names></name>, <name><surname>Giuliano</surname><given-names>M</given-names></name>, <name><surname>De Placido</surname><given-names>S</given-names></name>, <name><surname>Rosa</surname><given-names>R</given-names></name>, <etal>et al</etal><article-title>Mechanisms of lapatinib resistance in HER2-driven breast cancer</article-title>. <source>Cancer Treat Rev</source>. <year>2015</year>;<volume>41</volume>(<issue>10</issue>):<fpage>877</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctrv.2015.08.001</pub-id><?supplied-pmid 26276735?><pub-id pub-id-type="pmid">26276735</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref063">
      <label>63</label>
      <mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Yang</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>H</given-names></name>. <article-title>Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer</article-title>. <source>Mol Med Rep</source>. <year>2014</year>;<volume>10</volume>(<issue>4</issue>):<fpage>1703</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2014.2466</pub-id><?supplied-pmid 25109897?><pub-id pub-id-type="pmid">25109897</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref064">
      <label>64</label>
      <mixed-citation publication-type="journal"><collab>Cancer Genome Atlas N</collab>. <article-title>Comprehensive molecular portraits of human breast tumours</article-title>. <source>Nature</source>. <year>2012</year>;<volume>490</volume>(<issue>7418</issue>):<fpage>61</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/nature11412</pub-id><?supplied-pmid 23000897?><pub-id pub-id-type="pmid">23000897</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref065">
      <label>65</label>
      <mixed-citation publication-type="journal"><name><surname>Plautz</surname><given-names>GE</given-names></name>, <name><surname>Modi</surname><given-names>A</given-names></name>, <name><surname>Wang</surname><given-names>LX</given-names></name>. <article-title>ERBB2 amplicon passenger genes: A novel class of breast cancer antigens</article-title>. <source>Cancer Res</source>. <year>2014</year>:<fpage>2897</fpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref066">
      <label>66</label>
      <mixed-citation publication-type="journal"><name><surname>Hansen</surname><given-names>TV</given-names></name>, <name><surname>Vikesaa</surname><given-names>J</given-names></name>, <name><surname>Buhl</surname><given-names>SS</given-names></name>, <name><surname>Rossing</surname><given-names>HH</given-names></name>, <name><surname>Timmermans-Wielenga</surname><given-names>V</given-names></name>, <name><surname>Nielsen</surname><given-names>FC</given-names></name>. <article-title>High-density SNP arrays improve detection of HER2 amplification and polyploidy in breast tumors</article-title>. <source>BMC Cancer</source>. <year>2015</year>;<volume>15</volume>(<issue>1</issue>):<fpage>35</fpage>.<pub-id pub-id-type="pmid">25655188</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref067">
      <label>67</label>
      <mixed-citation publication-type="journal"><name><surname>Terkelsen</surname><given-names>T</given-names></name>, <name><surname>Haakensen</surname><given-names>VD</given-names></name>, <name><surname>Saldova</surname><given-names>R</given-names></name>, <name><surname>Gromov</surname><given-names>P</given-names></name>, <name><surname>Hansen</surname><given-names>MK</given-names></name>, <name><surname>Stockmann</surname><given-names>H</given-names></name>, <etal>et al</etal><article-title>N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome</article-title>. <source>Mol Oncol</source>. <year>2018</year>;<volume>12</volume>(<issue>6</issue>):<fpage>972</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/1878-0261.12312</pub-id><?supplied-pmid 29698574?><pub-id pub-id-type="pmid">29698574</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref068">
      <label>68</label>
      <mixed-citation publication-type="journal"><name><surname>Fridman</surname><given-names>WH</given-names></name>, <name><surname>Pages</surname><given-names>F</given-names></name>, <name><surname>Sautes-Fridman</surname><given-names>C</given-names></name>, <name><surname>Galon</surname><given-names>J</given-names></name>. <article-title>The immune contexture in human tumours: impact on clinical outcome</article-title>. <source>Nat Rev Cancer</source>. <year>2012</year>;<volume>12</volume>(<issue>4</issue>):<fpage>298</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3245</pub-id><?supplied-pmid 22419253?><pub-id pub-id-type="pmid">22419253</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref069">
      <label>69</label>
      <mixed-citation publication-type="journal"><name><surname>Kallio</surname><given-names>MA</given-names></name>, <name><surname>Tuimala</surname><given-names>JT</given-names></name>, <name><surname>Hupponen</surname><given-names>T</given-names></name>, <name><surname>Klemela</surname><given-names>P</given-names></name>, <name><surname>Gentile</surname><given-names>M</given-names></name>, <name><surname>Scheinin</surname><given-names>I</given-names></name>, <etal>et al</etal><article-title>Chipster: user-friendly analysis software for microarray and other high-throughput data</article-title>. <source>BMC Genomics</source>. <year>2011</year>;<volume>12</volume>(<issue>1</issue>):<fpage>507</fpage>.<pub-id pub-id-type="pmid">21999641</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref070">
      <label>70</label>
      <mixed-citation publication-type="journal"><name><surname>Lohse</surname><given-names>M</given-names></name>, <name><surname>Bolger</surname><given-names>AM</given-names></name>, <name><surname>Nagel</surname><given-names>A</given-names></name>, <name><surname>Fernie</surname><given-names>AR</given-names></name>, <name><surname>Lunn</surname><given-names>JE</given-names></name>, <name><surname>Stitt</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>40</volume>(Web Server issue):<fpage>W622</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks540</pub-id><?supplied-pmid 22684630?><pub-id pub-id-type="pmid">22684630</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref071">
      <label>71</label>
      <mixed-citation publication-type="journal"><name><surname>Eijssen</surname><given-names>LM</given-names></name>, <name><surname>Jaillard</surname><given-names>M</given-names></name>, <name><surname>Adriaens</surname><given-names>ME</given-names></name>, <name><surname>Gaj</surname><given-names>S</given-names></name>, <name><surname>de Groot</surname><given-names>PJ</given-names></name>, <name><surname>Muller</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>User-friendly solutions for microarray quality control and pre-processing on ArrayAnalysis.org</article-title>. <source>Nucleic Acids Res</source>. <year>2013</year>;<volume>41</volume>(Web Server issue):<fpage>W71</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt293</pub-id><?supplied-pmid 23620278?><pub-id pub-id-type="pmid">23620278</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref072">
      <label>72</label>
      <mixed-citation publication-type="journal"><name><surname>Sharov</surname><given-names>AA</given-names></name>, <name><surname>Schlessinger</surname><given-names>D</given-names></name>, <name><surname>Ko</surname><given-names>MS</given-names></name>. <article-title>ExAtlas: An interactive online tool for meta-analysis of gene expression data</article-title>. <source>J Bioinform Comput Biol</source>. <year>2015</year>;<volume>13</volume>(<issue>6</issue>):<fpage>1550019</fpage><pub-id pub-id-type="doi">10.1142/S0219720015500195</pub-id><?supplied-pmid 26223199?><pub-id pub-id-type="pmid">26223199</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref073">
      <label>73</label>
      <mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>J</given-names></name>, <name><surname>Gill</surname><given-names>EE</given-names></name>, <name><surname>Hancock</surname><given-names>RE</given-names></name>. <article-title>NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data</article-title>. <source>Nat Protoc</source>. <year>2015</year>;<volume>10</volume>(<issue>6</issue>):<fpage>823</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2015.052</pub-id><?supplied-pmid 25950236?><pub-id pub-id-type="pmid">25950236</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref074">
      <label>74</label>
      <mixed-citation publication-type="journal"><name><surname>Bryan</surname><given-names>K</given-names></name>, <name><surname>Jarboui</surname><given-names>MA</given-names></name>, <name><surname>Raso</surname><given-names>C</given-names></name>, <name><surname>Bernal-Llinares</surname><given-names>M</given-names></name>, <name><surname>McCann</surname><given-names>B</given-names></name>, <name><surname>Rauch</surname><given-names>J</given-names></name>, <etal>et al</etal><article-title>HiQuant: Rapid Postquantification Analysis of Large-Scale MS-Generated Proteomics Data</article-title>. <source>J Proteome Res</source>. <year>2016</year>;<volume>15</volume>(<issue>6</issue>):<fpage>2072</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.5b01008</pub-id><?supplied-pmid 27086506?><pub-id pub-id-type="pmid">27086506</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref075">
      <label>75</label>
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>YE</given-names></name>, <name><surname>Kutnetsov</surname><given-names>L</given-names></name>, <name><surname>Partensky</surname><given-names>A</given-names></name>, <name><surname>Farid</surname><given-names>J</given-names></name>, <name><surname>Quackenbush</surname><given-names>J</given-names></name>. <article-title>WebMeV: A Cloud Platform for Analyzing and Visualizing Cancer Genomic Data</article-title>. <source>Cancer Res</source>. <year>2017</year>;<volume>77</volume>(<issue>21</issue>):<fpage>e11</fpage>–<lpage>e4</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0802</pub-id><?supplied-pmid 29092929?><pub-id pub-id-type="pmid">29092929</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref076">
      <label>76</label>
      <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>C</given-names></name>, <name><surname>Xu</surname><given-names>K</given-names></name>, <name><surname>Guo</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Yan</surname><given-names>Q</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <etal>et al</etal><article-title>PANDA-view: an easy-to-use tool for statistical analysis and visualization of quantitative proteomics data</article-title>. <source>Bioinformatics</source>. <year>2018</year>;<volume>34</volume>(<issue>20</issue>):<fpage>3594</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty408</pub-id><?supplied-pmid 29790911?><pub-id pub-id-type="pmid">29790911</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref077">
      <label>77</label>
      <mixed-citation publication-type="journal"><name><surname>Torre</surname><given-names>D</given-names></name>, <name><surname>Lachmann</surname><given-names>A</given-names></name>, <name><surname>Ma'ayan</surname><given-names>A</given-names></name>. <article-title>BioJupies: Automated Generation of Interactive Notebooks for RNA-Seq Data Analysis in the Cloud</article-title>. <source>Cell Syst</source>. <year>2018</year>;<volume>7</volume>(<issue>5</issue>):<fpage>556</fpage>–<lpage>61 e3</lpage>. <pub-id pub-id-type="doi">10.1016/j.cels.2018.10.007</pub-id><?supplied-pmid 30447998?><pub-id pub-id-type="pmid">30447998</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref078">
      <label>78</label>
      <mixed-citation publication-type="journal"><name><surname>Vallabh</surname><given-names>S</given-names></name>, <name><surname>Kartashov</surname><given-names>AV</given-names></name>, <name><surname>Barski</surname><given-names>A</given-names></name>. <article-title>Analysis of ChIP-Seq and RNA-Seq Data with BioWardrobe</article-title>. <source>Methods Mol Biol</source>. <year>2018</year>;<volume>1783</volume>:<fpage>343</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-7834-2_17</pub-id><?supplied-pmid 29767371?><pub-id pub-id-type="pmid">29767371</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref079">
      <label>79</label>
      <mixed-citation publication-type="journal"><name><surname>Lopez-Fernandez</surname><given-names>H</given-names></name>, <name><surname>Blanco-Miguez</surname><given-names>A</given-names></name>, <name><surname>Fdez-Riverola</surname><given-names>F</given-names></name>, <name><surname>Sanchez</surname><given-names>B</given-names></name>, <name><surname>Lourenco</surname><given-names>A</given-names></name>. <article-title>DEWE: A novel tool for executing differential expression RNA-Seq workflows in biomedical research</article-title>. <source>Comput Biol Med</source>. <year>2019</year>;<volume>107</volume>:<fpage>197</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2019.02.021</pub-id><?supplied-pmid 30849608?><pub-id pub-id-type="pmid">30849608</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1007665.ref080">
      <label>80</label>
      <mixed-citation publication-type="journal"><name><surname>Murie</surname><given-names>C</given-names></name>, <name><surname>Woody</surname><given-names>O</given-names></name>, <name><surname>Lee</surname><given-names>AY</given-names></name>, <name><surname>Nadon</surname><given-names>R</given-names></name>. <article-title>Comparison of small n statistical tests of differential expression applied to microarrays</article-title>. <source>BMC Bioinformatics</source>. <year>2009</year>;<volume>10</volume>(<issue>1</issue>):<fpage>45</fpage>.<pub-id pub-id-type="pmid">19192265</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<sub-article id="pcbi.1007665.r001" article-type="editor-report">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1007665.r001</article-id>
    <title-group>
      <article-title>Decision Letter 0</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Darling</surname>
          <given-names>Aaron E.</given-names>
        </name>
        <role>Software Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2020 Aaron E. Darling</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>Aaron E. Darling</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article id="rel-obj001" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1007665" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>0</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">1 Aug 2019</named-content>
    </p>
    <p>Dear Dr Papaleo,</p>
    <p>Thanks for your Presubmission Inquiry regarding your manuscript 'CAncer bioMarker Prediction Pipeline (CAMPP) - A standardised framework for the analysis of quantitative biological data.'. Although we think that your study is interesting, we do not think it provides a significant enough advance or broad enough appeal to our readership for us to consider publishing in PLOS Computational Biology. However, we very much appreciate your wish to present your work in an open-access publication and therefore want to alert you to an alternative that you may find attractive. PLOS ONE is a unique swift, high-volume system for the publication of peer-reviewed research from any scientific discipline. PLOS ONE aims to exploit the full potential of the web to make the most of every piece of research; if you would like to submit your work to PLOS ONE, please visit <ext-link ext-link-type="uri" xlink:href="http://www.plosone.org">www.plosone.org</ext-link> and submit your work online. </p>
    <p>Editor's specific comments:</p>
    <p>Please excuse the delayed response on your presubmission inquiry. Unfortunately, the software does not provide the strength of advance in functionality that we are seeking in manuscripts for the Software section of PLOS Computational Biology. Thanks for considering PLOS and I wish you well on your journey to communicate this work to the scientific community.</p>
    <p>Thanks for considering PLOS Computational Biology, and good luck with your work.</p>
    <p>Yours sincerely,</p>
    <p>Aaron E. Darling</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
  </body>
</sub-article>
<sub-article id="pcbi.1007665.r002" article-type="author-comment">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1007665.r002</article-id>
    <title-group>
      <article-title>Author response to Decision Letter 0</article-title>
    </title-group>
    <related-article id="rel-obj002" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1007665" related-article-type="editor-report"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="author-response-date">29 Aug 2019</named-content>
    </p>
    <supplementary-material content-type="local-data" id="pcbi.1007665.s003">
      <label>Attachment</label>
      <caption>
        <p>Submitted filename: <named-content content-type="submitted-filename">ReplyPLOSComp.docx</named-content></p>
      </caption>
      <media xlink:href="pcbi.1007665.s003.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </body>
</sub-article>
<sub-article id="pcbi.1007665.r003" article-type="aggregated-review-documents">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1007665.r003</article-id>
    <title-group>
      <article-title>Decision Letter 1</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Software Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2020 Mihaela Pertea</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>Mihaela Pertea</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article id="rel-obj003" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1007665" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">1 Oct 2019</named-content>
    </p>
    <p>Dear Dr Papaleo,</p>
    <p>Thank you very much for submitting your manuscript 'CAncer bioMarker Prediction Pipeline (CAMPP) - A standardised framework for the analysis of quantitative biological data.' for review by PLOS Computational Biology. Your manuscript has been fully evaluated by the PLOS Computational Biology editorial team and in this case also by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the manuscript as it currently stands. While your manuscript cannot be accepted in its present form, we are willing to consider a revised version in which the issues raised by the reviewers have been adequately addressed. We cannot, of course, promise publication at that time.</p>
    <p>Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p>
    <p>Your revisions should address the specific points made by each reviewer. Please return the revised version within the next 60 days. If you anticipate any delay in its return, we ask that you let us know the expected resubmission date by email at <email>ploscompbiol@plos.org</email>. Revised manuscripts received beyond 60 days may require evaluation and peer review similar to that applied to newly submitted manuscripts.</p>
    <p>In addition, when you are ready to resubmit, please be prepared to provide the following:</p>
    <p>(1) A detailed list of your responses to the review comments and the changes you have made in the manuscript. We require a file of this nature before your manuscript is passed back to the editors.</p>
    <p>(2) A copy of your manuscript with the changes highlighted (encouraged). We encourage authors, if possible to show clearly where changes have been made to their manuscript e.g. by highlighting text.</p>
    <p>(3) A striking still image to accompany your article (optional). If the image is judged to be suitable by the editors, it may be featured on our website and might be chosen as the issue image for that month. These square, high-quality images should be accompanied by a short caption. Please note as well that there should be no copyright restrictions on the use of the image, so that it can be published under the Open-Access license and be subject only to appropriate attribution.</p>
    <p>Before you resubmit your manuscript, please consult our Submission Checklist to ensure your manuscript is formatted correctly for PLOS Computational Biology: <ext-link ext-link-type="uri" xlink:href="http://www.ploscompbiol.org/static/checklist.action">http://www.ploscompbiol.org/static/checklist.action</ext-link>. Some key points to remember are:</p>
    <p>- Figures uploaded separately as TIFF or EPS files (if you wish, your figures may remain in your main manuscript file in addition).</p>
    <p>- Supporting Information uploaded as separate files, titled Dataset, Figure, Table, Text, Protocol, Audio, or Video.</p>
    <p>- Funding information in the 'Financial Disclosure' box in the online system.</p>
    <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com">https://pacev2.apexcovantage.com</ext-link> PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>.</p>
    <p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/ploscompbiol/s/submission-guidelines#loc-materials-and-methods">here</ext-link>. </p>
    <p>We are sorry that we cannot be more positive about your manuscript at this stage, but if you have any concerns or questions, please do not hesitate to contact us.</p>
    <p>Sincerely,</p>
    <p>Mihaela Pertea</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Mihaela Pertea</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
    <p>A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact <email>ploscompbiol@plos.org</email> immediately:</p>
    <p>[LINK]</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>
      <bold>Please note here if the review is uploaded as an attachment.</bold>
    </p>
    <p>Reviewer #1: The authors present a new data analysis pipeline for commonly used omics data (gene expression microarray and RNA-seq data, as well as mass-spec data). The pipeline uses well tested and commonly used methods in the field (Limma, glmnet, etc.), which is positive. The statistical assumptions and approaches appear sound, and the pipeline produces biologically meaningful output when applied to a real microarray dataset (ER+/- negative identifies ESR1 as top differentially expressed gene). My key main concern relates to the usability and the target user group of the pipeline. See below for detailed comments:</p>
    <p>## Major issues</p>
    <p>### Target user group</p>
    <p>The authors write that “this pipeline is targeted towards bioinformatic software users and computational-inclined bio-researchers.” My main concern is that computational-inclined researchers will prefer to piece together their own pipeline (even if using exactly the same components as CAMPP) to control and test key parameters in the analysis. Instead, I think the pipeline could be very useful for researchers that have limited computational know-how. However, this group of people may likely need a much more thorough and user-friendly explanation of the output than what CAMPP currently provides. From a quick inspection of the output, CAMPP generally provides very technical plots that will be difficult to interpret for the average user with limited statistical expertise.</p>
    <p>### RNA-seq data</p>
    <p>Most current gene expression data is generated using RNA-seq. It is unfortunate that the authors do not provide an example and validation using this type of data. The authors could for example compare ER+/- RNA-seq data from TCGA and compare with their microarray results. This would also allow the authors to demonstrate the scalability of their software (e.g. running on 300-500 samples and 40.000 variables).</p>
    <p>### Minor</p>
    <p>### Data distributional checks</p>
    <p>The pipeline runs a set of distributional checks on 10 randomly selected variables. This analysis is summarised in a set of plots for each variable. A key problem here is that this information is not summarised and presented well to the user. Assuming that the average user has limited statistical expertise, it is not clear how they should act on this information. Furthermore, it is not clear how the outcome of these checks affect the downstream analysis pipeline.</p>
    <p>## Compute requirements</p>
    <p>Information on computational/hardware requirements should be more specific. How much RAM is needed to run 300-500 samples and 40.000 variables? What’s the runtime? Can the software take advantage of multi-core systems?</p>
    <p>### Batch effects</p>
    <p>The authors write that the pipeline can adjust for batch effects, but it is not clear how the user supplies batch information in the input data.</p>
    <p>## Comparison with other pipelines, table 2</p>
    <p>The information in table 2 is not easy to digest. Firstly, information for CAMPP is not included(?). Secondly, the table is very large (2-pages), so it’s not easy to compare pipelines.</p>
    <p>Reviewer #2: Terkelsen et al. present a useful pipeline for the detection of biomarkers from input data matrices such as gene expression or protein abundance values. It covers various aspects of data processing, including normalization and batch effect correction. The tool is available via github and can easily be installed in R. The code is well structured and sufficiently commented. The user manual guides users through installation and usage. It has an open source license and can thus be modified and used freely. It is suitable as a starting place for biomedical researchers familiarizing themselves with biomarker discovery. I have some suggestions for improvements:</p>
    <p>CAMPP depends on R packages which tend to change over time. To avoid that CAMPP quickly becomes unusable I strongly suggest one of the following options:</p>
    <p>- build a docker container</p>
    <p>- use the R packrat package to bind CAMPP to a static version of its dependencies</p>
    <p>Table 2 is very clunky. Could this be solved with a table that has checkmarks when features are implemented in one of the tools?</p>
    <p>Minor:</p>
    <p>- ElasticNet: the parameter alpha for balancing ridge and lasso regression should be adjustable</p>
    <p>- It is not clear to me why all four columns are needed for survival analysis. Age is useful to consider but not strictly necessary to perform survival analysis. Is it used as a confounder?</p>
    <p>- typo: trail -&gt; trial</p>
    <p>**********</p>
    <p>
      <bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
    </p>
    <p>Large-scale datasets should be made available via a public repository as described in the <italic>PLOS Computational Biology</italic>
<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/ploscompbiol/s/data-availability">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
    <p>Reviewer #1: Yes</p>
    <p>Reviewer #2: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
    <p>Reviewer #1: No</p>
    <p>Reviewer #2: Yes: Markus List</p>
  </body>
</sub-article>
<sub-article id="pcbi.1007665.r004" article-type="aggregated-review-documents">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1007665.r004</article-id>
    <title-group>
      <article-title>Decision Letter 2</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Software Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2020 Mihaela Pertea</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>Mihaela Pertea</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article id="rel-obj004" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1007665" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>2</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">18 Jan 2020</named-content>
    </p>
    <p>Dear Prof. Papaleo,</p>
    <p>We are pleased to inform you that your manuscript 'CAncer bioMarker Prediction Pipeline (CAMPP) - A standardized framework for the analysis of quantitative biological data' has been provisionally accepted for publication in PLOS Computational Biology.</p>
    <p>Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch within two working days with a set of requests.</p>
    <p>Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.</p>
    <p>IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.</p>
    <p>Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.</p>
    <p>Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. </p>
    <p>Best regards,</p>
    <p>Mihaela Pertea</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Mihaela Pertea</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
    <p>***********************************************************</p>
    <p>Reviewer's Responses to Questions</p>
    <p>Comments to the Authors:</p>
    <p>Please note here if the review is uploaded as an attachment.</p>
    <p>Reviewer #1: The authors have addressed all my concerns. I would like to congratulate the authors on a much improved manuscript. Especially the run time information (table 1), the more user friendly table 2, and the references to additional information in the user manual.</p>
    <p>Minor point:</p>
    <p>Many important details are provided in the user manual, which is great. I would encourage the authors to reference this manual more frequently in the main manuscript text. For example referencing the new RNA-seq analysis of TCGA breast cancer. The authors could for example reference this analysis in the discussion, and comment on whether the analysis results are generally concordant with the microarray analysis (eg1. ESR1 overexpression in ER+/Luminal tumors, and HER2 over expression in HER2+ tumors).</p>
    <p>Reviewer #2: The authors have addressed all of my previous comments.</p>
    <p>**********</p>
    <p>Have all data underlying the figures and results presented in the manuscript been provided?</p>
    <p>Large-scale datasets should be made available via a public repository as described in the </p>
    <p>PLOS Computational Biology</p>
    <p><ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/ploscompbiol/s/data-availability">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
    <p>Reviewer #1: Yes</p>
    <p>Reviewer #2: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p>Do you want your identity to be public for this peer review?</p>
    <p> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
    <p>Reviewer #1: No</p>
    <p>Reviewer #2: Yes: Markus List</p>
  </body>
</sub-article>
<sub-article id="pcbi.1007665.r005" article-type="editor-report">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1007665.r005</article-id>
    <title-group>
      <article-title>Acceptance letter</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Software Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2020 Mihaela Pertea</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>Mihaela Pertea</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article id="rel-obj005" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1007665" related-article-type="reviewed-article"/>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">5 Mar 2020</named-content>
    </p>
    <p>PCOMPBIOL-D-19-01225R2 </p>
    <p>CAncer bioMarker Prediction Pipeline (CAMPP) - A standardized framework for the analysis of quantitative biological data</p>
    <p>Dear Dr Papaleo,</p>
    <p>I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.</p>
    <p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. </p>
    <p>Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
    <p>Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! </p>
    <p>With kind regards,</p>
    <p>Matt Lyles</p>
    <p>PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom <email>ploscompbiol@plos.org</email> | Phone +44 (0) 1223-442824 | <ext-link ext-link-type="uri" xlink:href="http://ploscompbiol.org">ploscompbiol.org</ext-link> | @PLOSCompBiol</p>
  </body>
</sub-article>
